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Abstract 21 
The biological functions of modified aminophospholipids (APL) have become a topic of interest 22 
during the last two decades, and distinct roles have been found for these biomolecules in both 23 
physiological and pathological contexts. Modifications of APL include oxidation, glycation, and 24 
adduction to electrophilic aldehydes, altogether contributing to a high structural variability of 25 
modified APL. An outstanding technique used in this challenging field is mass spectrometry (MS). 26 
MS has been widely used to unveil modified APL of biological interest, mainly when associated 27 
with soft ionization methods (electrospray and matrix-assisted laser desorption ionization) and 28 
coupled with separation techniques as liquid chromatography. This review summarizes the 29 
biological roles and the chemical mechanisms underlying APL modifications and comprehensively 30 
reviews the current MS-based knowledge that has been gathered until now for their analysis. The 31 
interpretation of the MS data obtained by in vitro-identification studies is explained in detail. The 32 
perspective of an analytical detection of modified APL in clinical samples is explored, highlighting 33 
the fundamental role of MS in unveiling APL modifications and their relevance in pathophysiology. 34 
 35 
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I. Introduction  72 
Phosphatidylethanolamine (PE) and phosphatidylserine (PS) are the two classes of 73 
glycerophospholipids named aminophospholipids (APL), as they bear a free amine in the polar head 74 
group. In mammalian cells, PE and PS are mainly confined to the inner leaflet of the membrane 75 
(Schick, Kurica, and Chacko 1976; Higgins and Evans 1978) where they are responsible for both 76 
structural and signaling roles. They allow membranes to be fluid as well as impermeable to water and 77 
solutes, mediate communication among cells and provide a membrane anchor for signaling 78 
macromolecules (Vance and Tasseva 2013). PE is the second most abundant phospholipid class in 79 
cell membranes of mammalian organisms, making up 20% of the whole phospholipid profile, while 80 
PS is present in a minor amount, constituting 2-10% of all phospholipids (Vance 2008). The 81 
biological functions of APL are considerably dependent on their location in the outer or in the inner 82 
leaflet on the membrane. Upon physiological conditions, PE and PS are mainly confined to the inner 83 
leaflet, maintained by specific flippases, which show a higher selectivity for PS (Daleke 2003), and 84 
scramblases (Bevers, Comfurius, and Zwaal 1983; Connor and Schroit 1990; Schroit and Zwaal 1991; 85 
Connor et al. 1992; Daleke and Lyles 2000). This specific location is crucial for PS signaling events. 86 
Externalized PS is a known activator of the blood-clotting cascade (Higgins and Evans 1978; Bevers, 87 
Comfurius, and Zwaal 1983; Connor and Schroit 1990; Connor et al. 1992; Daleke and Lyles 2000; 88 
Daleke 2003) and a hallmark of cells facing apoptosis (Fadok et al. 2001; Zwaal, Comfurius, and 89 
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Bevers 2005; Balasubramanian, Mirnikjoo, and Schroit 2007; Segawa et al. 2014). In mammalian 90 
cells, PE is involved in the modulation of the cell membrane curvature (Cullis and De Kruijff 1978; 91 
Verkleij et al. 1984). The presence of PE in the double layer was also associated with the regulation 92 
of contractile ring disassembly during cytokinesis of mammalian cells (Emoto and Umeda 2000) and 93 
the arrangement of Golgi membrane fusion in early-divided mitotic cells (Pécheur et al. 2002). 94 
Furthermore, PE can modify several proteins in mammalian cells, acting as a donor of ethanolamine 95 
moiety (Menon and Stevens 1992; Signorell et al. 2008). Table 1 provides an overview of current 96 
knowledge on the functions and roles of PE and PS in mammalian cells. 97 
APL are prone to be modified by oxidation (Domingues et al. 2009; Simões et al. 2010; Maciel 98 
et al. 2011; Melo, Santos, et al. 2013), glycation (Simões et al. 2010; Maciel, da Silva, et al. 2013; 99 
Melo, Silva, et al. 2013; Annibal et al. 2016), and reactive molecules such as electrophilic aldehydes 100 
(Bernoud-Hubac et al. 2004; Bacot et al. 2007). These changes in native APL may occur under 101 
physiological and pathological conditions through non-enzymatic reactions with reactive oxygen 102 
species (ROS), glucose, and other carbonyl compounds, or through enzyme-catalyzed reactions, 103 
generating a vast number of differently modified derivatives which display several biological 104 
functions. Oxidized PS (ox-PS) is externalized in cell membranes as an important “eat me” marker 105 
of apoptosis, and several studies highlighted it as a more potent signal for activated macrophages 106 
when compared to native PS (Kagan et al. 2002; Koty et al. 2002; Fabisiak et al. 2005; Greenberg et 107 
al. 2006). In addition to its interaction with macrophages, ox-PS mediates other biological functions 108 
that controversially relate it to the modulation of the immune system, from the inhibition of peripheral 109 
T-cells proliferation in human blood (Seyerl et al. 2008) to the induction of cytokine production in 110 
monocytes and dendritic cells (Silva et al. 2012). Also, PE oxidized by ROS (ox-PE) was found to be 111 
an active component of oxidized low-density lipoproteins (ox-LDL), that mediates the binding 112 
between platelets and annexin (Zieseniss et al. 2001). Furthermore, several biological roles have been 113 
investigated for ox-PE generated by lipoxygenase (LOX) in activated human or murine blood cells 114 
(Thomas et al. 2010; Zhao et al. 2011; Hammond et al. 2012). More recently, Kagan et al. (Kagan et 115 
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al. 2016) reported the central role of PE oxidation products with modifications in arachidonic acid 116 
and adrenic acid chains in the mediation of ferroptosis, a controlled cell death process. Moreover, PE 117 
and PS can react with glucose or electrophilic aldehydes and form adducts, which biological functions 118 
are far from being understood. The formation of glycated species and advanced glycation end 119 
products (AGE) of PE were reported in LDL incubated with glucose (Ravandi, Kuksis, and Shaikh 120 
2000). Glycated PE (gly-PE) was also detected in red blood cells from both healthy and diabetic 121 
subjects (Ravandi et al. 1996; Lertsiri, Shiraishi, and Miyazawa 1998; Fountain et al. 1999; Nakagawa 122 
2005). Interestingly, Simões et al. (Simões et al. 2013b; Simões et al. 2013a) reported that glycated 123 
PE species are inducers of a pro-inflammatory phenotype in several populations of human peripheral 124 
immune cells. Conversely, only one study reported the occurrence of a PS AGE in red blood cells 125 
from healthy subjects (Fountain et al. 1999). This study provided evidence that glycation of PS is also 126 
likely to occur in vivo, despite the authors could not detect an increase in the concentration of the 127 
same product in plasma samples from diabetic subjects (Fountain et al. 1999) . Aldehyde-modified 128 
APL (al-PE and al-PS) were also highlighted as a family of bioactive molecules. Al-PE pyrrole 129 
adducts present in LDL from normolipidemic volunteers were found to enhance the viability of 130 
macrophages (Riazy et al. 2011). Guo et al. (Guo et al. 2011) treated human umbilical vein endothelial 131 
cells (HUVEC) with al-PE and observed an increase in the expression of monocyte adhesion 132 
molecules, leading to endothelial dysfunction and inflammation. A comprehensive view of the 133 
biological activities modified APL is reported in Table 2, which consists of a summary of the 134 
functions that have been so far investigated for each group of derivatives. Moreover, Table 2 merges 135 
the studies reporting the occurrence of modified APL in models of inflammatory diseases and clinical 136 
samples from inflammation-related pathologies, including diabetes, atherosclerosis, Alzheimer’s 137 
disease (AD) and cystic fibrosis. 138 
Even though the biological relevance of modified APL is evident, a link between the structural 139 
changes in APL, the biological function of the modified derivatives and their occurrence as 140 
biomarkers of diseases has not been identified yet. To this end, it is necessary to be able to predict 141 
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and to understand the type of modifications that can occur in vivo upon pathophysiological conditions. 142 
In parallel, it is of fundamental importance to develop analytical strategies aimed to characterize the 143 
structural complexity of modified APL and detect these biomolecules in biological samples. In the 144 
following section, the chemistry of APL modifications will be reviewed, sorting the chemical 145 
reactions that can induce their modification. The remaining sections of this review will 146 
comprehensively examine the information that mass spectrometry (MS-)based approaches have 147 
provided for the analysis of modified APL, in vitro and biological samples, over the last two decades. 148 
The description of the structural modifications that can occur is accompanied by detailed explanations 149 
of the MS and MS/MS data that have been acquired for identification, structural characterization, 150 
detection and quantification of modified APL. 151 
 152 
II. Chemistry of APLs Modifications 153 
 154 
APL can undergo several modifications, which overall lead to a variety of products of 155 
biological relevance. Figure 1 proposes a schematic representation of the modifications that have 156 
been described so far for APL. The chemical reactions leading to modified APL can be categorized 157 
as follows: 158 
A. Oxidation of the fatty acyl chains (Khaselev and Murphy 1999; Gugiu et al. 2006; Maskrey 159 
et al. 2007; Tyurin et al. 2008; Tyurina et al. 2008; Domingues et al. 2009; Tyurin et al. 2009; Simões 160 
et al. 2010; Thomas et al. 2010; Tyurina et al. 2010; Lloyd T. Morgan et al. 2010; Tyurina, Tyurin, 161 
et al. 2011; Tyurina, Kisin, et al. 2011; Clark et al. 2011; Hammond et al. 2012; Melo, Santos, et al. 162 
2013; Melo, Silva, et al. 2013; Maciel, Faria, et al. 2013; Simões et al. 2013a); 163 
B. Oxidation of the polar head (Carr, van den Berg, and Winterbourn 1998; Richter et al. 164 
2008; Simões et al. 2010; Üllen et al. 2010; Maciel et al. 2011; Melo, Santos, et al. 2013; Maciel et 165 
al. 2014); 166 
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C. Adduction of glucose to the polar head with or without further oxidation of the adduct 167 
(glycation and glyco-oxidation) (Ravandi, Kuksis, and Myher 1995; Ravandi et al. 1996; Requena et 168 
al. 1997; Lertsiri, Shiraishi, and Miyazawa 1998; Pamplona et al. 1998; Fountain et al. 1999; 169 
Breitling-Utzmann et al. 2001; Nakagawa 2005; Shoji et al. 2010; Simões et al. 2010; Sookwong et 170 
al. 2011; Maciel, Faria, et al. 2013; Maciel, da Silva, et al. 2013; Annibal et al. 2016); 171 
D. Adduction of aldehydes to the polar head (Bhuyan et al. 1986; Guichardant et al. 1998; 172 
Bacot 2003; Amarnath et al. 2004; Tsuji et al. 2003; Zamora and Hidalgo 2003; Bernoud-Hubac et 173 
al. 2004; Stadelmann-Ingrand, Pontcharraud, and Fauconneau 2004; Hisaka et al. 2010; Bacot et al. 174 
2007). 175 
 176 
A. Oxidation of the fatty acyl chains 177 
 178 
Oxidation of the fatty acyl chains esterified to APL has been correlated with radical-mediated 179 
or enzyme-catalyzed oxidation reactions. Radical-mediated oxidation of fatty acyl chains usually 180 
relies on ROS as initial effectors of the modification pathway. ROS are generated in vivo by different 181 
sources, such as the mitochondrial electron-transport chain and NAD(P)H oxidases, and participate 182 
in the physiological metabolism of mammalian cells (Dröge 2002; Murphy 2009). Under oxidative 183 
stress, the equilibrium between cellular detoxification and generation of ROS is lost in favor of an 184 
excess of oxidants species. Thus, high concentrations of ROS mediate a randomly extensive oxidative 185 
damage to biomolecules, including lipids (reviewed by Dröge) (Dröge 2002). Oxidative stress can 186 
also be induced in vitro or ex vivo through a set of chemical, physical and enzymatic systems able to 187 
mimic the biological occurrence of the oxidation reaction. These biomimetic systems are used for the 188 
characterization of the oxidized APL in vitro and ex vivo, which is necessary for structure-biological 189 
activity studies and facilitates the development of targeted methods for the detection and the 190 
quantification of these molecules in vivo. A list of biomimetic systems that have been used so far for 191 
APL oxidation is reported in Table 3. The most common biomimetic systems are reported in Figure 192 
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2 and include Fenton reaction, 2,2'-Azobis(2-amidinopropane) dihydrochloride (AAPH), 193 
photosensitization and lipoxygenases (LOX). 194 
Except for MPO, which catalyzes the formation of a non-radical ROS (HOCl), most of the 195 
biomimetic methods grouped in Table 3 lead to the production of partially-reduced oxygen species 196 
(OH, O2-, 1O2) and other free radicals (e.g., R-O-O from AAPH). Free radicals mediate the 197 
hydrogen abstraction and the subsequent generation of a carbon-centered radical which promptly 198 
reacts with O2, leading to the formation of one or more hydroperoxyl derivatives. These radicals are 199 
particularly unstable and easily get stabilized by abstracting further (bis-)allylic hydrogen atoms from 200 
surrounding lipid molecules, leading to the formation of non-radical fatty acyl hydroperoxides (R-O-201 
O-H). Consequently, metal cations such as Fe2+ (in the case of Fenton reaction) or Cu2+, catalyze the 202 
decomposition of hydroperoxides into alkoxyl radicals (RO). These radicals may abstract carbon-203 
centered hydrogen from an adjacent lipid molecule and generate hydroxides (R-O-H), or further 204 
degrade into other chain-propagation radicals as alkyls (R), hydroxyl-alkyls (HOR), epoxy-alkyls 205 
(OR) and epoxy-peroxyls (OROO) (Reis and Spickett 2012). Esterified APL hydroperoxides can 206 
also cyclize and form a 5-membered ring that cleaves, forming a subclass of products named isoketals 207 
(isoLGs) (Salomon 2005; Li et al. 2009). 208 
Lipid oxidation derivatives that are named long chain oxidation products contain one or 209 
several oxygen atoms inserted on the fatty acyl chains, as in the case of hydroperoxy or hydroxy, keto 210 
and epoxy-derivatives. However, radical intermediates as alkoxyl radicals can further degrade 211 
through a β-cleavage of the C-C bond between the oxygenated carbon atom and the unsaturation in 212 
vinylic position. This cleavage leads to the formation of esterified aldehydes, keto-aldehydes, 213 
hydroxy-aldehydes, carboxylic acids, keto-carboxylic acids and hydroxy-carboxylic acids, named 214 
short chain oxidation products (Figure 1) (Gugiu et al. 2006; Domingues et al. 2009; Maciel, Faria, 215 
et al. 2013). When radical-radical reactions occur, in some cases due to antioxidant molecules, the 216 
radical-based oxidation process reaches the termination phase (Wefers and Sies 1988; Tadolini et al. 217 
2000). 218 
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 219 
B. Oxidation of the polar heads 220 
 221 
Among the ROS summarized in Table 3, the ones inducing one-electron oxidation on 222 
unsaturated fatty acyl chains have also been found to mediate radical-mediated oxidation of the polar 223 
head for both PE (Melo, Santos, et al. 2013) and PS (Maciel et al. 2011; Maciel et al. 2014). The 224 
serine center in the polar head of PS has hydrogen linked to the α-carbon, which is easily abstracted 225 
under radical attack, leading to an α-alkoxyl derivative (Maciel et al. 2011). The oxidation of the α-226 
alkoxyl further proceeds to polar head derivatives modified as terminal acetic acid, terminal 227 
acetamide, terminal hydroxy acetaldehyde and terminal hydroperoxy acetaldehyde (Maciel et al. 228 
2011). These modifications were observed for the first time in a study in which oxidation of PS was 229 
carried out in vitro through the Fenton reaction (Maciel et al. 2011). Later on, the oxidation of PS 230 
polar head to terminal acetic acid was found to occur in human keratinocytes treated with AAPH 231 
(Maciel et al. 2014). Similarly, in vitro irradiation of PE standards with white light in the presence of 232 
cationic porphyrins as photosensitizers (photo-oxidation) led to oxidative deamination of the 233 
ethanolamine group, with the generation of the polar head modified as terminal acetaldehyde (Figure 234 
1) (Melo, Santos, et al. 2013). 235 
Hypohalous acids as HOCl can also modify the polar head of PE via two-electron oxidation 236 
mechanism on the free amino group. This reaction runs by the initial formation of a chloroamine and, 237 
upon HOCl excess, continues with the formation of a dichloramine, which eventually loses two moles 238 
of HCl and leads to a terminal nitrile derivative (Carr, van den Berg, and Winterbourn 1998; Richter 239 
et al. 2008; Üllen et al. 2010). 240 
 241 
C. Adduction of glucose to the polar head (glycation and glyco-oxidation) 242 
 243 
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The amino group present in the polar head of APL is reactive towards electrophilic moieties 244 
as carbonyl groups. In fact, several published works mentioned the reactivity of the amino groups of 245 
PE and PS towards glucose and the consequent formation of glycated APL (Ravandi, Kuksis, and 246 
Myher 1995; Ravandi et al. 1996; Lertsiri, Shiraishi, and Miyazawa 1998; Oak, Nakagawa, and 247 
Miyazawa 2000; Nakagawa 2005; Simões et al. 2010; Sookwong et al. 2011; Maciel, da Silva, et al. 248 
2013; Maciel, Faria, et al. 2013; Melo, Silva, et al. 2013; Annibal et al. 2016). APL glycation occurs 249 
via reaction between the amino group of the APL polar heads and the carbonyl moiety of glucose, 250 
initially leading to a Schiff-base derivative which promptly establishes an equilibrium with the 251 
Amadori ketoamine (Simões et al. 2010; Annibal et al. 2016). Glycated APL can be further modified 252 
if radical driven oxidation occurs during or after the glycation. Both the Schiff-base and the Amadori 253 
derivatives were found to undergo oxidation on the fatty acyl chains and the glycated polar heads 254 
when ROS were present, in a process that is identified as glyco-oxidation, and leads to the production 255 
of AGE of APL (Simões et al. 2010; Melo, Silva, et al. 2013; Maciel, da Silva, et al. 2013; Maciel, 256 
Faria, et al. 2013; Simões et al. 2013a; Annibal et al. 2016). When the radical mechanism involves 257 
the polar head glycated as Schiff base, the hydrogen atom on the methylene adjacent to the imine 258 
bond is abstracted, leading to peroxyl and alkoxyl radicals. These are often stabilized through 259 
reduction to the carbonyl. However, if the radical reaction occurs on the Amadori derivative, the 260 
oxidation mainly affects the sugar moiety through sequential backbone cleavages (Simões et al. 2010; 261 
Maciel, da Silva, et al. 2013; Annibal et al. 2016) (Figure 1).  262 
 263 
D. Adduction of aldehydes to the polar head 264 
 265 
The oxidative degradation of lipids generates a variety of low-molecular-weight aldehydes 266 
including hydroxy-alkenals, keto-alkenals, γ-keto-aldehydes (Frankel et al. 1977; Benedetti, 267 
Comporti, and Esterbauer 1980; Lee and Blair 2000) and isoLGs (Salomon 2005) (reviewed by Reis 268 
and Spickett) (Reis and Spickett 2012). These lipid-derived aldehydes contain several electrophilic 269 
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centers, which can form covalent adducts with the free amino groups in the polar heads of APL. It 270 
has been reported for isoLG a reaction rate with PE that was 4.4-fold faster than the reaction between 271 
isoLG and lysine (Amarnath et al. 2004). Bernoud-Hubac et al. studied the mechanism of adduction 272 
between isoLG and PE, showing that the reaction runs with an initial formation of a Schiff base, that 273 
quickly forms a stable pyrrole through a cyclization (Bernoud-Hubac et al. 2004). On the other hand, 274 
the reaction between APL and hydroxy-alkenals was found to occur mainly by Michael addition 275 
(Guichardant et al. 1998; Bacot et al. 2007), even though adducts formed by the Schiff base-pyrrole 276 
pathway were also reported for the reaction of PE with 4,5(E)-epoxy-2(E)-heptenal (Zamora and 277 
Hidalgo 2003). 278 
More recently, Vazdar et al. employed 1H nuclear magnetic resonance spectroscopy, Fourier-279 
transform infrared spectroscopy and MS to study the reactivity of PE towards 4-hydroxy-2-nonenal 280 
(HNE) and 4-oxo-2-nonenal (ONE) (Vazdar et al. 2017). This study highlighted that PE-HNE 281 
adducts, both Michael and Schiff base, preferentially cyclized towards hemiacetal and pyrrole 282 
derivatives, in contrast with PE-ONE adducts that did not tend to form cyclic derivatives. 283 
The characterization and the detection of modified APL currently rely on platforms capable 284 
of performing specific and sensitive analyzes. Gas chromatography (GC) coupled to MS (GC-MS) 285 
has been widely used to analyze oxidized fatty acyl chains of phospholipids in their non-esterified 286 
form, as well as modified polar heads from APL, but it is not suitable for direct analysis of intact 287 
modified APL (Spickett et al. 2010). Presently, tandem MS using soft ionization methods is the most 288 
used platform in the analysis of the complex network of PE and PS modified structures, both in vitro 289 
and in biological samples. The next section reviews and describes all the MS strategies that have so 290 
far been used in the analysis of modified APL. 291 
 292 
 293 
III. MS-Based Strategies for the Analysis of APL Modifications 294 
 295 
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The development of soft ionization methods, such as electrospray ionization (ESI) (Yamashita 296 
and Fenn 1984) and matrix-assisted laser desorption ionization (MALDI) (Tanaka et al. 1988; Karas 297 
and Hillenkamp 1988), made the MS analysis of intact biomolecules possible, opening a new world 298 
of MS-based approaches that has strongly grown through the last 20 years. The introduction of high-299 
resolution MS analyzers in the last decade led to several advantages in the field of lipidomics, 300 
including reduced overlap of species in the mass spectrum (due to discrimination at 1-3 ppm or even 301 
sub-ppm level) and reduced analysis time (reviewed by Ghaste, Mistrik and Shulaev) (Ghaste, 302 
Mistrik, and Shulaev 2016). The following sections will review the current state of understanding of 303 
the information that MS-based analytical strategies have provided for all the known APL 304 
modifications 305 
 306 
A. Applications of GC-MS in the analysis of modified APL 307 
 308 
Since APL are non-volatile compounds, their analysis by GC-MS can only be carried out after 309 
the first step of hydrolysis of the ester bonds linking the fatty acids and the polar head to the glycerol 310 
backbone. In a subsequent step, the fatty acids and the polar head released by the hydrolytic treatment 311 
are derivatized with organic acids to produce volatile esters as, for example, trifluoroacetyl, acetyl 312 
and methyl esters (van Kuijk et al. 1985; Requena et al. 1997; Fountain et al. 1999). GC-MS typically 313 
uses electron ionization (EI) as ionization technique, which is characterized by a high in-source 314 
fragmentation that frequently causes the loss of structure of the molecular ion, hindering its 315 
observation. However, even though in EI-MS the molecular ion can be absent after the ionization 316 
process, information about its structure can be provided by the comparison of its in-source 317 
fragmentation pattern with the in-source fragmentation pattern of standards, or by direct interpretation 318 
of the fragmentation patterns.  319 
GC-MS has been used to detect AGE of APL bearing glyco-oxidative modifications on the 320 
ethanolamine or serine polar heads. The AGE of PE known as carboxymethyl-PE (CM-PE) is a 321 
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product of PE glyco-oxidation which has been quantified in vivo through GC-MS analysis of its 322 
hydrolysis product, carboxymethyl-ethanolamine (CM-Etn) (Requena et al. 1997; Pamplona et al. 323 
1998). The experimental approach was based on acid hydrolysis of CM-PE that produced the free 324 
carboxymethylated polar head (CM-Etn). Subsequently, CM-Etn was derivatized as a trifluoroacetyl-325 
methyl ester (TFAME) and quantified through GC-MS in single ion monitoring (SIM) mode 326 
(Requena et al. 1997; Pamplona et al. 1998). This methodology allowed the quantitative assessment 327 
of CM-Etn in mitochondrial membranes of several mammals (Pamplona et al. 1998) as well as in 328 
lipid extracts of red blood cell membranes of healthy and diabetic subjects (Requena et al. 1997). In 329 
another study, two glycation and glyco-oxidation products of APL, namely N-(Glucitol)PE and 330 
carboxymethyl-PS (CM-PS), were similarly detected and quantified by GC-MS. N-(Glucitol)PE and 331 
CM-PS were hydrolyzed in acid conditions as described above, with the production of the free, 332 
modified polar heads N-(Glucitol)ethanolamine (GE) and carboxymethyl-serine (CM-Ser), 333 
respectively. The modified polar heads were derivatized as N,O-acetyl methyl esters and finally 334 
analyzed by GC-MS in SIM mode (Fountain et al. 1999). In this study, the derivatized polar heads 335 
were quantified in the lipid extracts of human red blood cells from healthy and diabetic patients, 336 
showing an increased content of GE, but not CM-Ser, in the samples of the diabetic patients when 337 
compared to nondiabetic. 338 
GC-MS has also been used to assess the reactivity of PE polar head with fatty aldehydes 339 
generated by lipid peroxidation. Bacot (Bacot 2003) studied the in vitro reactivity of the ethanolamine 340 
group of PE with 4-hydroxy-2-hexenal (HHE), HNE and 4-hydroxydodeca-(2,6)-dienal (HDDE). 341 
Adducted PE were hydrolyzed, and the resulting ethanolamine-hydroxyalkenal adducts were 342 
derivatized as pentafluorobenzyloximes trimethylsilyl esters before GC-MS analysis (Bacot 2003). 343 
In subsequent work, the same author and others detected PE-hydroxyalkenals Michael adducts in 344 
human blood platelets and retinas of streptozocin-induced diabetic rats (Bacot et al. 2007). In this 345 
study, Michael-adducted PE were subjected to basic hydrolysis, and the resulting ethanolamine-346 
alkenals moieties were derivatized as trifluoroacetyl esters before the GC-MS analysis. In another 347 
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study, aldehyde-carbonylation products of PE with long-chain fatty aldehydes (e.g., pentadecanal, 348 
heptadecanal, heptadecenal) were observed through GC-MS analysis (Stadelmann-Ingrand, 349 
Pontcharraud, and Fauconneau 2004). These carbonylation products were observed in rat cortex 350 
homogenates that were submitted to UV light or Fe2+-induced oxidation, after basic methanolysis and 351 
derivatization of the modified ethanolamine as trimethylsilyl ether (Stadelmann-Ingrand, 352 
Pontcharraud, and Fauconneau 2004). All these works show that GC-MS has undoubtedly been one 353 
of the most important analytical techniques in the analysis of lipid modification, and still plays a 354 
crucial role in classical lipidomic studies (Li et al. 2011). However, due to several disadvantages such 355 
elaborate sample preparation, fragmentation of the molecular ions in the EI source and risk of 356 
degradation for thermolabile molecules, the relevance of this method in the study of APL 357 
modification is diminishing. As consequence of these drawbacks, MS analysis of modified APL has 358 
started to be performed mainly using soft ionization methodologies (ESI, MALDI) that preserve the 359 
structure of the analyte and, in the case of ESI, can be easily coupled with liquid chromatographic 360 
separations.  361 
 362 
B. Applications of ESI-MS and MALDI-MS in the analysis of modified APL 363 
 364 
Under ESI-MS and MALDI-MS analysis, APL can ionize in both negative and positive ions 365 
modes, with the formation of predominant [M-H]- ions and [M+H]+ ions, respectively (Pulfer and 366 
Murphy 2003). Despite PS can also be analyzed in positive ions mode as [M+H]+ ions, the 367 
identification and characterization of PS by MS is preferentially made in negative ions mode, 368 
probably due to the presence of the carboxylic acid group in the polar head (Koivusalo et al. 2001; 369 
Pulfer and Murphy 2003). 370 
When aiming to unveil APL modifications, the analysis of mass spectra generated by direct 371 
infusion MS or by liquid chromatography (LC-)MS runs of mixtures of native and modified APL is 372 
technically simple, interpretation of results is straightforward, and the first level of information 373 
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regarding the formation of new molecular structures is provided. When the ESI-MS spectra of 374 
modified APL are compared with an ESI-MS spectrum acquired in control conditions, the new ions 375 
correspondent to modified APL appearing in the former spectrum and the mass shifts can be classified 376 
into the following regions (Domingues, Reis, and Domingues 2008): 377 
- Long chain oxidation products region, characterized by ions that result from the insertion of 378 
one or more oxygen atoms on the unsaturated fatty acyl chain and therefore show higher m/z 379 
values than the native APL. These ions are usually attributed to epoxy-, keto-, hydroxy-, 380 
hydroperoxy- and polyhydroxy-derivatives; 381 
- Polar head oxidation products region, characterized by ions that result from deamination or 382 
decarboxylation reactions occurring in the polar heads, and therefore show lower m/z values 383 
than the native APL. 384 
- Adducts region, characterized by ions that result from the reaction of the free nucleophilic 385 
amino group of APL with carbonyl moieties of sugars (e.g. glycation/glyco-oxidation 386 
derivatives of PE and PS) and reactive aldehydes/ketones/carboxylic acids generated in the 387 
late stages of the fatty acyl chain-shortening oxidative degradations (e.g. HHE, HNE, acrolein, 388 
malonaldehyde, hexanoic acid). Ions of these adducts usually show higher m/z values than the 389 
native APL; 390 
- Short chain oxidation products region, characterized by ions that result from the oxidative 391 
cleavages of the unsaturated fatty acyl chains and therefore can be observed as ions with lower 392 
m/z values than the native APL. Shortened APL usually bear carbonyl species on the sn2 393 
position such as aldehydes, keto-aldehydes, hydroxy-aldehydes, as well as carboxylic acids, 394 
keto-carboxylic acids, hydroxycarboxylic acids. Oxygen insertions on the fatty acyl chains, 395 
as well as products from adduction of sugars and carbonyl species, can also occur on chain-396 
shortened oxidation products leading to other ions with m/z values lower than the native APL, 397 
although these types of oxidative modifications have been scarcely reported. 398 
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- Lyso-APL region, characterized by ions that result from the hydrolysis of the ester linkage 399 
between the glycerol backbone and a fatty acyl chain. 400 
 401 
1. Identification of long-chain and short-chain oxidation products 402 
 403 
The first step when identifying long-chain oxidation products of APL is the observation in the 404 
mass spectra of new peaks with different mass shifts. These shifts include ions with + 16 Da in the 405 
case of hydroxyl derivatives, + 32 Da in the case of hydroperoxy (or di-hydroxy) derivatives, and + 406 
14 Da in the case of keto or epoxy derivatives (16-2 Da). In Figure 3 we exemplify the presence of 407 
these ions for oxidized 1-palmitoyl-2-linoleoyl-sn-3-glycerophosphoethanolamine (ox-PLPE) and in 408 
Figure 4 (Panel C) for oxidized 1-palmitoyl-2-linoleoyl-sn-3-glycerophosphoserine (ox-PLPS). Long 409 
chain oxidation product with multiple oxidation motifs are detected by identifying mass increments 410 
corresponding to combinations of 16 Da and 14 Da. This approach allows proposing several oxidative 411 
modifications as hydroxy, di- or poly-hydroxy, hydroperoxy, as well as hydroxy-peroxy, keto and 412 
epoxy combined with hydroxy or hydroperoxy (Tyurina et al. 2008; Tyurin et al. 2008; Tyurin et al. 413 
2009; Domingues et al. 2009; Tyurina et al. 2010; Tyurina, Tyurin, et al. 2011; Tyurina, Kisin, et al. 414 
2011; Maciel et al. 2011; Maciel, Faria, et al. 2013; Melo, Silva, et al. 2013; Melo, Santos, et al. 2013; 415 
Ni, Milic, and Fedorova 2015). Figure 3B shows a full ESI-MS spectrum ox-PLPE acquired in 416 
positive ion mode, which allowed to identify long chain oxidation products bearing 1 oxygen atom, 417 
2, 3 and 4 oxygen atoms (Domingues et al. 2009). Figure 4C shows a full ESI-MS spectrum of ox-418 
PLPS acquired in negative ion mode, reporting long chain oxidation products bearing 1, 2 and 3 419 
oxygen atoms (Maciel et al. 2011). 420 
Short chain oxidation products esterified to an oxidatively truncated carbon chain on the sn-2 421 
position are detected at lower m/z values than the unmodified APL. These species can bear either a 422 
terminal aldehydic or carboxylic group, as reported by several authors (Gugiu et al. 2006; Domingues 423 
et al. 2009; Simões et al. 2010; Maciel et al. 2011; Maciel, Faria, et al. 2013). These products can be 424 
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further oxidized in the shortened carbon chain with additional keto/epoxy, hydroxy and hydroperoxy 425 
moieties (Maciel et al. 2011; Maciel, Faria, et al. 2013). As for long-chain derivatives, short chain 426 
oxidation products can be analyzed by MS either in positive and negative ion mode. Oxidation 427 
products with shortened sn-2 fatty acyl chains (9 carbon atoms) were observed in the MS spectrum 428 
of ox-PLPE acquired in positive ion mode, depicted in Figure 3B (Domingues et al. 2009). The MS 429 
spectrum of ox-PLPS in negative ion mode, reported in Figure 4C, allows identifying similar short 430 
chain oxidation products described above for ox-PE, including esterified aldehydes and carboxylic 431 
acids with 9 carbon atoms (Maciel et al. 2011). The mass shifts characteristic for long and short chain 432 
oxidation of APL, that can be observed in full MS spectra, are summarized in Table 4. 433 
 434 
2. Identification of polar head oxidation products 435 
 436 
APL bearing an oxidative modification in the polar heads are easily detected in the MS spectra 437 
as peaks with lower m/z values than the unoxidized species (Maciel et al. 2011; Melo, Santos, et al. 438 
2013). Using photosensitized oxidation and direct infusion ESI-MS in negative ion mode, Melo et al. 439 
(Melo, Santos, et al. 2013) identified a series of long-chain oxidation products of PE bearing also an 440 
oxidative modification in the ethanolamine (Etn) polar head, which are summarized in Table 4. These 441 
PE modified in the polar head arose from the oxidative deamination of the Etn moiety of the polar 442 
head due to photo-oxidation. Hence they appeared in the MS spectra at odd m/z values with a mass 443 
shift of -1 Da when compared to the respective PE. In the case of 1-palmitoyl-2-oleoyl-sn-3-444 
glycerophosphoethanolamine (POPE), the authors identified the [M-H]- ion at m/z 731 as oxidized 445 
POPE with one oxygen insertion on the oleyl chain in sn-2 and the Etn polar head modified as terminal 446 
acetaldehyde (mass shift from native POPE corresponding to - 1 + 16 Da) (Figure 5). 447 
Maciel et al. (Maciel et al. 2011) identified several modifications in the polar head of PS 448 
species, formed during biomimetic oxidation with the Fenton reaction (Figure 4A). The oxidation 449 
products of PS with modified polar heads were fractionated by thin layer chromatography (TLC), 450 
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exploiting the difference of polarities induced by such modifications (Figure 4B). After scraping and 451 
lipid extraction, the modified PS separated in each TLC spots were analyzed by ESI-MS in negative 452 
ion mode (Figure 4C). The [M-H]- ions characteristic for PE and PS modified in the polar head are 453 
summarized in Table 4 (Maciel et al. 2011). 454 
 455 
3. Identification of glycation and glyco-oxidation products 456 
 457 
Glycation of APL on the polar heads can be observed in the MS spectra by observing peaks 458 
of the native APL with a mass shift of +162 Da (Simões et al. 2010; Maciel, Faria, et al. 2013; Maciel, 459 
da Silva, et al. 2013; Melo, Silva, et al. 2013; Annibal et al. 2016). If oxidative conditions are 460 
superimposed on glycated APL (glyco-oxidation), the radical-based oxygenation can preferentially 461 
affect the fatty acyl chains of the APL and leave the glycated polar head intact. In this case, when the 462 
glyco-oxidation mixture is analyzed by ESI-MS the following ions can be observed in the MS spectra 463 
(summarized in Table 5): 464 
(I) Short chain oxidation products with a glucose moiety adducted to the polar head: 465 
characterized by a negative mass shift due to the chain-shortening β-cleavage, plus a 466 
mass shift of + 162 Da due to the glycation (Simões et al. 2010; Maciel, Faria, et al. 467 
2013; Annibal et al. 2016); 468 
(II) Long chain oxidation products with a glucose moiety adducted to the polar head: 469 
characterized by mass shifts of different combinations of 16 Da and 16-2 Da, due to 470 
the oxygen insertions, plus a mass shift of + 162 Da due to the glycation (Simões et 471 
al. 2010; Melo, Silva, et al. 2013; Maciel, Faria, et al. 2013; Maciel, da Silva, et al. 472 
2013); 473 
Figure 6B shows an ESI-MS spectrum of a gly-ox-PLPE acquired in positive ion mode which 474 
shows the several short chains and long chain oxidation products, formed after oxidation of the fatty 475 
acyl chain (Simões et al. 2010). 476 
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If also the glycated polar head undergoes radical oxidation, the MS spectrum of a glyco-477 
oxidized mixture can include ions characterized by peculiar mass shifts: 478 
(I) Mass increments higher than + 162 Da identify glyco-oxidized APL bearing a glucose 479 
moiety with oxygen insertions (e.g. 162 Da + 14 Da = 176 Da) (Simões et al. 2010; 480 
Maciel, da Silva, et al. 2013; Melo, Silva, et al. 2013; Annibal et al. 2016); 481 
(II) Mass increments lower than +162 Da identify glyco-oxidized APL bearing an end-482 
product of glucose formed through oxidative cleavage (AGE) (e.g. +28 Da, +58 Da, 483 
+72 Da) (Simões et al. 2010; Maciel, da Silva, et al. 2013; Maciel, Faria, et al. 2013; 484 
Melo, Silva, et al. 2013; Annibal et al. 2016). 485 
As examples, the characteristic [M-H]- ions of POPS AGE identified by ESI-MS are depicted 486 
in Figure 7 (Maciel, da Silva, et al. 2013). 487 
 488 
4. Identification of aldehyde-adduction products 489 
 490 
ESI-MS has not been extensively used in the analysis of the adducts between APL and 491 
electrophilic aldehydes, except for few studies that focused on the characterization of PE adducts with 492 
iso-LGs (Bernoud-Hubac et al. 2004), HNE (Guichardant et al. 1998), and alkanals (Annibal et al. 493 
2014). There is currently a lack of studies aimed to characterize the potential adduction of PS with 494 
aldehydes and ketones. In what concern PE adducts, Guichardant et al. (Guichardant et al. 1998) 495 
identified the adducts formed by the incubation of 1,2-diheptadecanoyl-sn-3-496 
glycerophosphoethanolamine (DHPE) and HNE using ESI-MS in negative ion mode. The MS 497 
spectrum of the reaction products are shown in Figure 8, which clearly depicts the characteristic mass 498 
shifts of 120 Da, 138 Da, 156 Da, corresponding to cyclized Schiff base (a), Schiff base (b), and 499 
Michael adduct (c), respectively. More recently, Annibal et al. (Annibal et al. 2014) employed high-500 
resolution Orbitrap MS analysis to identify modified derivatives of 1,2-dipalmitoyl-sn-3-501 
glycerophosphoethanolamine (DPPE) arising from its incubation with hexanal and other alkanals. 502 
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The MS spectrum of the products of the reaction between DPPE and hexanal acquired in positive ion 503 
mode, shown in Figure 9A, shows new ions that have mass shifts corresponding to the sequential 504 
adductions of up to three hexanal molecules, resulting in a series of monomeric, dimeric, and trimeric 505 
covalent adducts. 506 
Nowadays, accurate mass analysis achievable by mass spectrometers equipped with high-507 
resolution analyzers allows a precise identification of modified APL using data from an MS scan. 508 
However, native and modified APL having the same m/z (isobaric species) can be generated within a 509 
reaction occurring in vitro or in vivo, and the structural features of the modified products can easily 510 
include constitutional isomers that would not be distinguished by using direct infusion MS data, and 511 
maybe even using LC separation in the case of isomers of position. Therefore, LC separation and 512 
MS/MS structural characterization are highly recommendable to confirm the identity of the 513 
modifications. The applications of LC and MS/MS in the structural characterization of modified APL 514 
will be addressed in detail in the next paragraphs of the present review. 515 
  516 
C. Applications of LC in the MS-based analysis of modified APL 517 
 518 
The improvements that LC-ESI-MS methods have brought to the field of lipidomics have 519 
already been acknowledged and reviewed (Li et al. 2011; Hyötyläinen and Orešič 2016; Sethi 520 
and Brietzke 2017). In fact, LC-MS has also played a key role in the analytical separation of 521 
modified APL, mainly for the following reasons:  522 
(I) Oxidation, glycation and aldehyde-adduction reactions generate several modified APL that 523 
might have very close m/z, not resolved by low-resolution instruments. Also, in more 524 
complex samples, native and modified species can be isobaric. Thus, LC-MS approaches 525 
allow the separation of these complex mixtures, based on the differences in the polarities 526 
within native and modified species (e.g., separation of hydroperoxy-PE, hydroxy-PE, and 527 
native PE); 528 
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(II) The ionization efficiency of the modified products can be decreased through ion 529 
suppression mediated by the native APL, which are often more abundant. In such case, 530 
chromatographic separation of the analyzed mixture would increase the sensitivity towards 531 
low-abundant species. 532 
(III) LC protocols allow the separation of constitutional isomers of modified APL. 533 
In most of the LC-MS protocols described in the literature for the analysis of ox-PE, reversed 534 
phase high-performance LC (RP-HPLC) was the preferred separation approach, allowing to resolve 535 
phospholipids by species through the interaction of the stationary phase with the fatty acyl chains. 536 
The insertion of oxygen atoms on the fatty acyl chains increase the polarity of the molecule and, 537 
consequently, in RP-HPLC oxidized APL elute earlier than native APL. C18 microbore columns with 538 
an internal diameter of 2 mm or 0.5 mm have been widely used in the chromatographic separation of 539 
ox-PE (Gugiu et al. 2006; Maskrey et al. 2007; Domingues et al. 2009; Thomas et al. 2010; Zemski 540 
Berry et al. 2010; Alwena H Morgan et al. 2010; Clark et al. 2011; Hammond et al. 2012). Microbore 541 
columns operate at low flow rates (e.g., 200 µL/min), increasing the sensitivity of the analysis. 542 
However, other LC-MS protocols for ox-PE have relied on C18 standard analytical columns (Khaselev 543 
and Murphy 1999; Hammond et al. 2012). Ox-PS analysis by LC-MS is a less explored field, yet 544 
Maciel et al. (Maciel, Faria, et al. 2013) performed a reverse phase separation of a mixture of long 545 
chain, short chain and polar head oxidation products of PS using a C5 microbore column. There are 546 
also examples of oxidative phospholipidomics studies in which the analysis of ox-PS species has been 547 
performed by normal phase HPLC (NP-HPLC) using silica microbore columns (Tyurina et al. 2010; 548 
Tyurina, Tyurin, et al. 2011). 549 
The first LC-MS protocols for gly-PE and glycated PS (gly-PS) were proposed in the nineties 550 
and relied on NP analytical columns. Adduction of the polar head to a glucose moiety increases the 551 
polarity of the molecule, hence in NP-HPLC glycated APL elute after native APL. This approach 552 
succeeded in the separation of native APL from their glycated derivatives, both in vitro (Ravandi, 553 
Kuksis, and Myher 1995) and in plasma of diabetic patients (Ravandi et al. 1996). RP-HPLC-MS has 554 
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also been carried out for the analysis of gly-PE. A C18 medium bore column has been used to separate 555 
Schiff bases and Amadori derivatives of PE in human erythrocytes (Breitling-Utzmann et al. 2001). 556 
Also, C18 microbore columns were used in an LC-MS/MS protocol aimed to quantify PE-AGE in 557 
human erythrocytes and blood plasma (CE-PE and CM-PE) (Shoji et al. 2010). More recently, C5 558 
microbore columns have been used in LC-MS/MS protocols aimed to the in vitro characterization 559 
and structural elucidation of  glyco-oxidized PE (gly-ox-PE) (Simões et al. 2010) and PS (gly-ox-PS) 560 
(Maciel, Faria, et al. 2013; Maciel, da Silva, et al. 2013). An overview of the LC columns that have 561 
so far been coupled to MS in the analysis of modified APL is reported in Table 6. 562 
 563 
D. Applications of MS/MS in the structural characterization of modified APL 564 
 565 
Modified APL can be identified in an MS analysis, preferably using high accuracy 566 
measurements and interpretation of the new ions appearing at characteristic mass shifts, as described 567 
earlier. Besides this, the modifications identified in MS scans should be confirmed by characterizing 568 
the new motifs of the modified APL. Such structural characterization can be achieved by MS/MS 569 
analysis, as we will describe in the following paragraphs. The characteristic fingerprints and the 570 
interpretation of the fragmentation patterns depend on the nature of the modification. Hence, the 571 
MS/MS strategies proposed until now for the characterization of modified APL will be addressed, 572 
organized by type of modification. 573 
 574 
1. Structural characterization of long-chain and short-chain oxidation products 575 
 576 
Long and short chain oxidation products can be characterized by the analysis of MS/MS 577 
spectra obtained either in positive or negative ion modes. While for native and modified PE both 578 
approaches have been used, in the case of PS the most suitable approach is the analysis of the 579 
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deprotonated molecular ions [M-H]-. MS/MS analysis of long chain and short chain oxidation 580 
products performed in the negative ion mode shows two significant families of typical fragment ions: 581 
(I) carboxylate anions of the fatty acids esterified to sn-1 (R1COO-) and sn-2 (R2COO-) 582 
positions; 583 
(II) ions arising the neutral losses of unmodified saturated sn1 acyl chains (R1=C=O, ketene, and 584 
R1COOH, carboxylic acid) and modified unsaturated sn2 acyl chains (R2’=C=O, ketene, and 585 
R2’COOH, carboxylic acid). 586 
MS/MS spectra of PE acquired in negative ion mode are usually characterized by a higher 587 
relative abundance (RA) of R1COO- anions compared to R2COO- anions. The opposite behavior (RA 588 
R2COO- >  RA R1COO-) is commonly observed for negative ion mode MS/MS spectra of PS (Pulfer 589 
and Murphy 2003). However, this behavior depends on the mass spectrometer and should always be 590 
confirmed using well-known standards. The MS/MS spectra of the [M-H]- molecular ion of oxidized 591 
APL allows the observation of the carboxylate anions of modified unsaturated FA which are usually 592 
characterized by the mass increments due to the insertion of n oxygen atoms (n x 16 Da, n x 16-2 593 
Da). Complementarily, the observation of the lyso-APL product ions (due to the neutral loss of the 594 
fatty acids as –RCOOH or –R=C=O) can be used to corroborate the oxidative modification (Tyurin 595 
et al. 2008; Tyurina et al. 2008; Tyurin et al. 2009; Tyurina et al. 2010; Maciel et al. 2011; Maciel, 596 
Faria, et al. 2013; Melo, Silva, et al. 2013; Maciel, da Silva, et al. 2013; Melo, Santos, et al. 2013). 597 
Figure 10 shows the MS/MS spectra of a long chain oxidation product of PAPE (PAPE + 4O), 598 
acquired in the negative ion mode using an Orbitrap-higher energy collision-induced dissociation 599 
(HCD) (PAPE + 4O, m/z 802.488); the characteristic fragments corresponding to the carboxylate 600 
anions can be seen, along with the characteristic neutral loss of modified saturated sn-2 as ketene 601 
(R2’=C=O). Figure 11 exemplifies the tandem MS of a short chain oxidation product of PE, namely 602 
1-(palmitoyl)-2-(5-oxovaleroyl)-PE, also acquired upon HCD activation in the negative ion mode; 603 
both the native and the shortened fatty acid carboxylate anions, corresponding to the sn-1 and the sn-604 
2 fatty acyl chains, respectively, are shown. 605 
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Besides the characteristic product ions described above for all the oxidized APL, the MS/MS 606 
analysis of the PS class in negative ion mode always shows a product ion formed due to the neutral 607 
loss of aziridine-2-carboxylic acid from the Ser moiety (identified as neutral loss of 87 Da, Figure 608 
12). This abundant neutral loss is typically observed in the negative ion mode MS/MS spectra of 609 
native and ox-PS molecular ions (Pulfer and Murphy 2003; Domingues, Reis, and Domingues 2008; 610 
Maciel et al. 2011; Maciel, Faria, et al. 2013). Hence, it can be used to further confirm the identity of 611 
a long chain or short chain oxidation product of PS, but it is absent in PS modified in the polar head 612 
group. PE tandem mass spectra do not display a typical neutral loss in negative ion mode. The identity 613 
of long chain and short chain oxidation products of PE can be further verified by MS/MS analysis in 614 
positive ion mode through the characteristic neutral loss the polar head (loss of phosphoethanolamine, 615 
141 Da) (Pulfer and Murphy 2003; Domingues, Reis, and Domingues 2008; Domingues et al. 2009; 616 
Simões et al. 2010). This neutral loss is a common feature of  the tandem mass spectra of native and 617 
ox-PE [M+H]+ ions, as it can be observed in Figures 13B and 13C. However, this typical neutral loss 618 
is also absent in the case of modifications in the polar head group in PE. 619 
Our group has published results from several ESI-MS/MS structural characterizations of 620 
oxidized APL, either in negative ion mode (Maciel et al. 2011; Maciel, Faria, et al. 2013) or in the 621 
positive ion mode (Domingues et al. 2009; Simões et al. 2010; Simões et al. 2013a). Long chain and 622 
short chain oxidation products of PE can be characterized by positive ion mode MS/MS. The 623 
complete interpretation of the fragmentation patterns should include the observation and 624 
interpretation of the following product ions (Domingues et al. 2009; Simões et al. 2010): 625 
(I) Ions arising from the neutral losses of the polar head (141 Da); 626 
(II) Ions arising from the neutral losses of unmodified saturated sn1 acyl chains (R1=C=O, 627 
ketene, and R1COOH, carboxylic acid) and modified unsaturated sn2 acyl chains 628 
(R2’=C=O, ketene, and R2’COOH, carboxylic acid); 629 
(III) Ions arising from the neutral losses of the fatty acyl chains plus the polar head; 630 
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(IV) Ions arising from the neutral loss of the polar head, plus the fragmentation of the C-C bond 631 
between a carbon atom bearing an oxygen insertion and the unsaturation in vinylic position.  632 
These typical product ions observed in MS/MS spectra in positive ion mode of ox-PE are exemplified 633 
in Figures 13B and 13C. These figures compare the positive LC-MS/MS spectra of two ox-PE 634 
isomers (PLPE + 3O) (Domingues et al. 2009); ions labelled as A, B and C were formed by the 635 
fragmentation occurring between the carbon atom bearing the hydroxyl or hydroperoxyl functional 636 
group and the adjacent double bond, thus were used to indicate which carbon atom was modified by 637 
the oxygenated moieties (Figures 13B and 13C). Domingues et al. (Domingues et al. 2009) also 638 
correlated the neutral loss of H2O2 (34 Da), that was observed for the ox-PLPE isomer in Figure 13C 639 
through the fragment ion at m/z 730.6, with the presence of a hydroperoxy moiety on the sn-2 fatty 640 
acyl chain. The neutral loss of H2O2 was also reported for PCs oxidized as hydroperoxy derivatives 641 
(Adachi et al. 2004; Adachi et al. 2005; Spickett et al. 2001; Reis et al. 2007). Such a neutral loss 642 
would not appear in the MS/MS spectra of hydroxylated species. Differently, multiple losses of H2O 643 
molecules (losses of n x 18 Da) are observed for poly-hydroxy derivatives, as exemplified in Figures 644 
13B and 10 (Tyurin et al. 2009). 645 
 646 
2. Structural characterization of polar head oxidation products 647 
 648 
The structural characterization of APL bearing an oxidized polar head group is a poorly 649 
explored topic that should deserve more attention. These molecules were found to be pro-650 
inflammatory factors in peripheral blood (Silva et al. 2012) and were detected in keratinocytes treated 651 
with the oxidant AAPH (Maciel et al. 2014). APL oxidative modifications of the polar head were 652 
characterized by negative ion mode MS/MS for ox-PS. The MS/MS spectra are characterized by the 653 
following features (Maciel et al. 2011): 654 
(I) Absence of the ions arising from the neutral loss of aziridine-2-carboxylic acid (-87 Da), 655 
typical of native PS; 656 
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(II) Carboxylate anions of the fatty acids esterified to sn-1 and sn-2 positions; 657 
(III) Ions arising from specific neutral losses due to the modification of Ser in the oxidized polar 658 
head. 659 
Figures 14A and 14 B show two MS/MS spectra of ox-PS bearing a modification in the polar 660 
head, acquired in negative ion mode upon collision-induced dissociation (CID) and HCD activation, 661 
respectively. In both the MS/MS spectra, the neutral loss of 87 Da from the precursor is not observed, 662 
yet it is possible to detect a neutral loss of 58 Da. This fragmentation pattern is characteristic for ox-663 
PS bearing a glycerophosphoacetic acid derivative in the polar head. The structures of this ion are 664 
depicted in Figure 14 and Figure 5A (Maciel et al. 2011). 665 
A summary of the main product ions that have been characterized by the MS/MS analysis of 666 
ox-PE and ox-PS in both positive and negative ion modes is reported in Table 4 667 
 668 
3. Structural characterization of glycation and glyco-oxidation products 669 
 670 
The MS/MS-based fingerprinting of glycated and glyco-oxidized APL relies on the 671 
interpretation of specific neutral losses, which allow confirming the adduction of a glucose moiety to 672 
the polar head. A correct reading of such neutral losses also allows the elucidation of the oxidative 673 
modifications that have eventually been introduced on the glycated polar head. A summary of the 674 
mass shifts and the characteristic neutral losses that have been observed in the MS/MS spectra of 675 
glycated and glyco-oxidized APL acquired in both positive and negative ion modes is reported in 676 
Table 5. Importantly, the neutral loss of phosphoethanolamine polar head from PE occurs upon 677 
MS/MS in positive ion mode, whereas the neutral loss of Ser from the polar head of PS takes place 678 
upon MS/MS in negative ion mode (Pulfer and Murphy 2003). Hence, the fragmentation in positive 679 
ion mode is preferred for the analysis of gly-PE and gly-ox-PE, since it allows to observe the neutral 680 
loss of the glycated polar head (Simões et al. 2010; Melo, Silva, et al. 2013; Annibal et al. 2016). 681 
Conversely, the analysis in negative ion mode is more suitable for gly-PS and gly-ox-PS, because it 682 
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allows the observation of the neutral loss of the glycated Ser moiety from the polar head (Maciel, da 683 
Silva, et al. 2013). However, MS/MS analysis in negative ion mode is also suitable for gly-PE and 684 
gly-ox-PE (Simões et al. 2010; Melo, Silva, et al. 2013). The MS/MS fragmentation of gly-PE in 685 
positive ion mode results in typical fragmentation patterns that include the following ions: 686 
(I) Ions arising from the neutral loss of 303 Da, due to the elimination of the 687 
phosphoethanolamine polar head (-141 Da) adducted to one glucose molecule (-162 Da) 688 
(Simões et al. 2010; Melo, Silva, et al. 2013; Annibal et al. 2016). Figure 15 shows an 689 
MS/MS spectrum of gly-PLPE acquired in positive ion mode, in which it is possible to 690 
observe a diagnostic neutral loss of polar head adducted to glucose (-303 Da).(Simões et 691 
al. 2010); 692 
(II) Ions arising from multiple neutral losses of H2O and H2CO, characteristic for the insertion 693 
of a glucose moiety (Wang et al. 2008; Simões et al. 2010). 694 
When the glycated polar head of gly-ox-PE is oxidized, different ions arising from neutral 695 
losses can be observed in the MS/MS spectra acquired in positive ion mode. These explanatory 696 
neutral losses from the parent molecular ion can be classified in two main groups (Table 5) (Simões 697 
et al. 2010; Shoji et al. 2010; Melo, Silva, et al. 2013; Annibal et al. 2016): 698 
(I) Ions arising from neutral losses greater than 303 Da, due to the elimination of the 699 
phosphoethanolamine polar head adducted to glucose, with additional oxygen 700 
insertions (e.g., glucuronic acid, glucose adducted to α-keto-etn) (Simões et al. 2010; 701 
Melo, Silva, et al. 2013; Annibal et al. 2016) (Simões, Simões, et al.; Melo, Silva, et 702 
al.; Annibal, Riemer, et al.); 703 
(II) Ions arising from neutral losses smaller than 303 Da, due to the elimination of the 704 
phosphoethanolamine polar head adducted to end-products of glucose oxidative 705 
cleavage (e.g., carboxymethyl, carboxyethyl, formamide, carbamino); Figure 16 706 
shows an MS/MS spectrum of gly-ox-PLPE acquired in positive ion mode. In this 707 
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case, the new structural feature is characterized by the neutral loss of glyco-oxidized 708 
polar head. 709 
The common fragmentation pathways observed in the negative ion mode MS/MS spectra of 710 
gly-PS and gly-PE are also characterized by specific product ions that are different from those 711 
observed in the positive ion mode. The following fragment ions are common to gly-PS and gly-PE, 712 
when analyzed in negative ion mode (Table 5) (Simões et al. 2010; Maciel, da Silva, et al. 2013; 713 
Maciel, Faria, et al. 2013): 714 
(I) Ions arising from the neutral loss of 162 Da, due to the elimination of the glucose 715 
moiety; 716 
(II) Carboxylate anions of the fatty acids, R1COO- and R2COO-. Nevertheless, it is still 717 
possible to observe oxidative modifications that can occur on the fatty acyl chains; 718 
(III) Ions formed by neutral losses of C3H6O3, C4H8H4, and C5H10O5 (-90, -120 Da and -719 
150 Da, respectively) due to the cleavage of the glucose moiety that occurs along the 720 
glycosidic linkages upon MS/MS (Asam and Glish 1997; Simões et al. 2007). 721 
As an illustration of these fragmentation patterns, Figure 17 shows the MS/MS fragmentation 722 
of gly-PLPE in negative ion mode, showing the characteristic neutral losses of glucose from the polar 723 
head (Simões et al. 2010). The fragmentation of gly-POPS in negative ion mode is shown in Figure 724 
18 and is characterized by the typical neutral losses of glycated Ser (Maciel, da Silva, et al. 2013). 725 
The MS/MS spectra acquired in negative ion mode of gly-ox-PS also show characteristic 726 
neutral losses. If the oxidation occurs on the glycated Ser moiety, the following diagnostic neutral 727 
losses can be observed (Table 5) (Maciel, da Silva, et al. 2013; Maciel, Faria, et al. 2013): 728 
(I) Ions arising from neutral losses greater than 249 Da, due to the elimination of the Ser 729 
moiety adducted to glucose with additional oxygen insertions; Figure 19B shows the 730 
MS/MS spectrum of gly-ox-POPS acquired in negative ion mode,  which highlights 731 
the oxidation of the glucose moiety adducted to the polar head (Maciel, da Silva, et al. 732 
2013); 733 
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(II) Ions arising from neutral losses smaller than 249 Da, due to the elimination of the Ser 734 
moiety adducted to end-products from glucose oxidative cleavage (AGE of glycated 735 
Ser).  736 
The MS/MS spectrum of gly-ox-POPS bearing an AGE of glycated Ser acquired in negative 737 
ion mode is depicted in Figure 20. This spectrum shows the characteristic fragmentation pattern of a 738 
derivative which is oxidatively shortened at C2 of the glucose moiety (Maciel, da Silva, et al. 2013). 739 
 740 
4. Structural characterization of aldehyde-adduction products 741 
 742 
Adducts of APL with aldehydes have been highlighted as bioactive molecules, able to promote 743 
macrophage viability (Riazy et al. 2011) and monocyte adhesion (Guo et al. 2011). MS/MS allowed 744 
the structural elucidation of several adducts of PE produced in-vitro using reactive products from 745 
lipid peroxidation as hexanoic acid (Tsuji et al. 2003) and iso-LGs (Bernoud-Hubac et al. 2004). 746 
Bernoud-Hubac and co-authors (Bernoud-Hubac et al. 2004) performed the structural 747 
characterization of the adducts formed by the reaction of PLPE and a mixture of synthetic iso-LGs. 748 
MS/MS in negative ion mode elucidated the structures of one AL-PE Schiff-base adduct and one AL-749 
PE pyrrole adduct. Figures 21 and 22 show two MS/MS spectra of AL-PLPE adducts, acquired in 750 
negative ion mode. The spectrum in Figure 21 shows the fragmentation pattern of the AL-PLPE 751 
pyrrole adduct (m/z 1031). The spectrum in Figure 22 shows the fragmentation pattern acquired in 752 
negative ion mode MS/MS of the second AL-PLPE (m/z 1035), that allowed its characterization as 753 
Schiff base adduct and the differentiation from the pyrrole adduct (Bernoud-Hubac et al. 2004). 754 
Annibal et al. (Annibal et al. 2014) performed an elegant structural characterization of a Schiff adduct 755 
formed by the reaction of DPPE and hexanal, based on multistage tandem MS analysis. The MS2, 756 
MS3 and MS4 spectra acquired in positive ion mode for the characterization of Schiff base DPPE-757 
hexanal are shown in Figure 23A, 23B, and 23C, respectively.  758 
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Upon the whole, unbiased LC-MS/MS analyzes of modified PE and PS allow the 759 
identification of the modified species by characteristic mass shifts in the MS spectra, and the 760 
structural characterization of the modifications by the acquisition of the MS/MS spectra. This 761 
knowledge can be further applied to the detection and the quantification of biologically relevant 762 
species in vivo, for example, by developing targeted MS-based analytical methods. The next section 763 
reviews the MS approaches that have so far been employed for the targeted analysis of modified APL. 764 
 765 
E. Targeted MS approaches for the detection of modified APL in biological samples 766 
 767 
The detailed knowledge acquired, based on the analysis of the MS/MS spectra of modified 768 
APL, allowed the development of MS-based targeted approaches, aimed at their detection and 769 
quantification ex-vivo or in-vivo. The targeted detection in cells or biofluids is fundamental, as it can 770 
relate the occurrence of modified APL with the biological mechanisms underpinning the onset of a 771 
disease, and validate these molecules as biomarkers of a pathological condition. The applications of 772 
the targeted MS approaches such as precursor ion scanning (PIS), neutral loss scanning (NLS) and 773 
single/multiple reaction monitoring (SRM/MRM) to detect or quantify modified APL in biological 774 
samples will be discussed in detail below. 775 
 776 
1. Precursor ion scanning (PIS) 777 
 778 
PIS identifies all the precursor ions that fragment in the collision cell to generate a selected 779 
reporter ion. The carboxylate anions of the fatty acyl chains esterified to the glycerol backbone 780 
(R1COO- and R2COO-) are typical reporter ions formed during the fragmentation of APL upon 781 
MS/MS in negative ion mode (Pulfer and Murphy 2003). In the case of long-chain oxidation products, 782 
the observation of characteristic mass shifts (n x 16 Da, n x 16-2 Da) on the carboxylate reporter ions 783 
confirms the insertion of oxygen atoms on the unsaturated acyl chains, as reported above. Several 784 
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studies used the carboxylate anion of hydroxy-arachidonic acid (hydroxy-eicosatetraenoic acid, 785 
HETE) as selected reporter ion for PIS analysis. LC-MS methods based on RP separation and PIS of 786 
the precursors of HETE (m/z 319) were employed to detect HETE-PE generated by LOXs in activated 787 
human platelets (Maskrey et al. 2007; Thomas et al. 2010), neutrophils (Clark et al. 2011) and 788 
monocytes/macrophages (Maskrey et al. 2007; Morgan et al. 2009). A similar PIS approach reported 789 
by Hammond et al. (Hammond et al. 2012) used the selection of the carboxylate anion of arachidonic 790 
acid bearing one keto insertion (keto-eicosatetraenoic acid, KETE). The authors employed an LC-791 
MS method based on RP separation and PIS with the selection of KETE as reporter ion (m/z 317.2), 792 
which detected KETE-containing PE generated by LOX in monocytes and macrophages of patients 793 
affected by cystic fibrosis. Morgan et al. (Lloyd T. Morgan et al. 2010) used a similar PIS approach 794 
in negative ion mode, by selecting the carboxylate anion of docosahexaenoic acid with the insertion 795 
one hydroxy group (hydroxy-docosahexaenoic acid, HDOHE) as fragment ion. The LC-MS method 796 
was based on the PIS of the HDOHE reporter ion at m/z 343 and detected four HDOHE-PE generated 797 
by 12-LOX in activated human platelets. 798 
Zemski Berry et al. (Zemski Berry et al. 2010) proposed a PIS approach based on the 799 
derivatization of PE with 4-(dimethylamino)benzoic acid (DMABA) for detecting ox-PE in RAW 800 
264.7 cells. In this study, the treatment of lipids extracted from RAW 264.7 cells with AAPH led to 801 
a complex mixture of native and ox-PE, which were separated by RP-HPLC, and detected by PIS 802 
using a peculiar ion formed during the fragmentation of ox-PE derivatized with D6-DMABA (m/z 803 
197.1) (Figure 24). The structures of the ox-PE precursor ions identified by PIS were elucidated by 804 
MS/MS, allowing the characterization of long chain and short chain oxidation products of PE (Zemski 805 
Berry et al. 2010). 806 
Maciel et al. (Maciel et al. 2014) reported a PIS approach for the detection of ox-PS 807 
derivatives in keratinocytes subjected to in vitro radical oxidation with AAPH. The authors studied 808 
the fragmentation of ox-PS with polar head modified as GPAA (Figures 4A and 14) by MS/MS in 809 
negative ion mode, observing the formation of the reporter ion at m/z 137.1 (HOPO3CH2COO-). 810 
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Subsequently, the PIS scan detected several oxidation derivatives of PS with polar head oxidized as 811 
GPAA in the oxidatively stressed cells  (Maciel et al. 2014).  812 
2. Neutral loss scanning (NLS) 813 
 814 
NLS identifies all the precursor ions that fragment in the collision cell by the loss of a reporter 815 
neutral fragment. Both AGE and early glycation products of PE have been detected using this tandem 816 
MS approach. Amadori gly-PE in plasma from diabetic patients were detected by scanning of the 817 
neutral loss of 303 Da, corresponding to the loss of glycated polar head and formation of a 818 
diacylglyceride ion (see also Figure 15 and Table 5) (Nakagawa 2005). In another study, profiling of 819 
the PE AGE CM-PE and CE-PE in human diabetic plasma was carried out by NLS of parent ions, 820 
yielding neutral losses of 199 Da and 213 Da, respectively, which again correspond to the loss of 821 
modified polar heads (Shoji et al. 2010). Also, Maciel et al. (Maciel et al. 2014) profiled PS oxidation 822 
products with polar head modified as GPAA in keratinocytes subjected to in vitro radical oxidation 823 
with AAPH, using an NLS of the reporter neutral fragment corresponding to the acetic acid moiety 824 
of GPAA (58 Da) as shown in Figure 14A. 825 
 826 
3. Single and multiple reaction monitoring (SRM/MRM) 827 
 828 
Reaction monitoring routines are more suitable when the presence of an analyte has been 829 
confirmed, and a quantitative assessment is required. In single reaction monitoring (SRM) a single 830 
fragmentation step is monitored, and the reporter ion that is selected is usually the most diagnostic 831 
and abundant among the ions characterizing the MS/MS pattern. If the fragmentation of the parent 832 
ion leads to several reporter ions which are diagnostic and intense, multiple transitions, from one 833 
precursor ion to one or more reporter ions, can be monitored. This approach is known as multiple 834 
reaction monitoring (MRM). 835 
Positive mode reaction monitoring has been used for detecting gly-PE in biological samples, 836 
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through the formation of the diacylglyceride derivative fragment ions arising from the loss of glucose-837 
adducted polar head (303 Da) (Nakagawa 2005; Sookwong et al. 2011). In these reports, the transition 838 
906.5 -> 603.7 was used to quantify Amadori-dioleoyl-PE in plasma from healthy and diabetic 839 
humans (Nakagawa 2005). Also, the transition 908.8 -> 605.7 was used to quantify Amadori-1-840 
stearoyl-2-oleoyl-PE in several tissues from healthy and diabetic rats (Sookwong et al. 2011). 841 
Similarly, CE-PE and CM-PE were quantified by reaction monitoring in human erythrocytes and 842 
blood plasma, using the transition leading to the elimination of modified polar head and formation of 843 
diglyceride product ion (Shoji et al. 2010). SRM and MRM were also used in the quantification of 844 
different ox-PE from rat tissues. Positive mode MRM was used to quantify 14 different short chain 845 
oxidation derivatives of PE in rat retina, by setting one specific parent-product transition for each 846 
oxidatively truncated analyte (Gugiu et al. 2006). 847 
Different isomers of long-chain oxidation products of PE are generated by LOXs in activated 848 
blood cells, including platelets, neutrophils, and monocytes/macrophages. In these cells, negative ion 849 
mode MRM based on the modified fatty acid carboxylate product ions as KETE (m/z 317) and HETE 850 
(m/z 319) has been used for detection and quantification of HETE-PE (Thomas et al. 2010; Clark et 851 
al. 2011; Morgan et al. 2009) and KETE-PE (Hammond et al. 2012) derivatives, respectively. 852 
 853 
 854 
IV. Conclusive remarks 855 
 856 
PE and PS, also named APL, are essential phospholipids that are found in the plasma 857 
membrane of mammalian cells, displaying structural and signaling roles. APL can be modified to 858 
oxidized, glycated, glyco-oxidized and aldehyde-adducted derivatives. Over the last 20 years, several 859 
studies have reported the bioactivities of modified APL and their occurrences in several 860 
inflammation-related pathologies, highlighting potential roles as signaling molecules and biomarkers 861 
of disease. However, structural complexity and low in vivo-concentration have represented the two 862 
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main challenges for the analysis of modified APL. MS is a sensible and selective analytical platform 863 
that has been fundamental in the identification, structural characterization, detection and 864 
quantification of modified APL. Some MS-based strategies have already provided brilliant insights 865 
on modified PE, with several studies focusing on its characterization in vitro and, to a lesser extent, 866 
on its detection in biological samples. Nevertheless, the literature focused on the MS analysis of APL 867 
modifications is still scarce, particularly in the case of PS. As a challenge for the future, a more 868 
comprehensive knowledge of the modifications that can occur in PE and PS is needed, relying on 869 
systematic experimental approaches that merge in vitro biomimetic methods to modern MS platforms. 870 
Databases of fragment ions of modified APL can be generated from an extensive in vitro 871 
characterization, and finally translated to MS-based targeted methods, which represent a reliable tool 872 
for the detection of these molecules in clinical samples. This bioanalytical knowledge, accompanied 873 
by a more detailed investigation of the biological functions of modified PE and PS, will contribute to 874 
unveil the implications of modified APL in, for example, inflammatory diseases, and will provide 875 
new biomarkers of highly-debilitating pathologies like cancer, diabetes, and atherosclerosis. 876 
 877 
V. Abbreviations 878 
 879 
AAPH 2,2'-Azobis(2-amidinopropane) dihydrochloride 880 
AD Alzheimer’s disease 881 
AGE advanced glycation end product(s) 882 
Al-PE aldehyde-PE 883 
Al-PS aldehyde-PS 884 
APL aminophospholipid 885 
CE carboxyethyl 886 
CID collision-induced dissociation 887 
CM carboxymethyl 888 
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DHPE 1,2-diheptadecanoyl-sn-3-glycerophosphoethanolamine 889 
DPPE 1,2-dipalmitoyl-sn-3-glycerophosphoethanolamine 890 
DPPS 1,2-dipalmitoyl-sn-3-glycerophosphoserine 891 
EI electronic impact 892 
ER endoplasmic reticulum 893 
ESI electrospray ionization 894 
Etn ethanolamine 895 
GC gas chromatography 896 
Gly-ox-PE glyco-oxidized PE 897 
Gly-ox-PS glyco-oxidized PS 898 
Gly-PE glycated PE 899 
Gly-PS glycated PS 900 
GPAA glycerophosphoacetic acid 901 
H2O2 hydrogen peroxide 902 
HCD higher energy collision-induced dissociation 903 
HDDE 4-hydroxydodeca-(2,6)-dienal  904 
HDOHE hydroxydocosahexaenoic acid  905 
HETE hydroxyeicosatetraenoic acid 906 
HHE 4-hydroxy-2-hexenal  907 
HNE 4-hydroxy-2-nonenal 908 
HUVEC human umbilical vein endothelial cells 909 
Iso-LG iso-ketal 910 
KETE keto-eicosatetraenoic acid 911 
LC liquid chromatography 912 
LDL low-density lipoprotein 913 
LOX lipoxygenase 914 
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MALDI matrix-assisted laser desorption/ionization 915 
MDA malondialdehyde 916 
MPO myeloperoxidase 917 
MRM multiple reaction monitoring 918 
MS mass spectrometry 919 
NL neutral loss 920 
NLS neutral loss scanning 921 
NP-HPLC normal phase high performance liquid chromatography 922 
O2 molecular oxygen 923 
O2-- superoxide radical 924 
1O2 singlet oxygen 925 
OH hydroxyl radical 926 
ONE 4-oxo-2-nonenal 927 
Ox-PE oxidized PE 928 
Ox-PS oxidized PS 929 
PE phosphatidylethanolamine 930 
PLPE 1-palmitoyl-2-linoleoyl-sn-3-glycerophosphoethanolamine 931 
PLPS 1-palmitoyl-2-linoleoyl-sn-3-glycerophosphoserine 932 
POPE 1-palmitoyl-2-oleoyl-sn-3-glycerophosphoethanolamine 933 
PS phosphatidylserine 934 
RA relative abundance 935 
ROS reactive oxygen species 936 
RP-HPLC reversed phase high performance liquid chromatography 937 
Ser serine 938 
SIM single ion monitoring 939 
SRM single reaction monitoring 940 
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TFAME trifluoroacetyl-methyl ester 941 
TIC total ion count 942 
TLC thin layer chromatography 943 
VEGF vascular endothelial growth factor 944 
 945 
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Table 1. Main biological activities of phosphatidylserine (PS) and phosphatidylethanolamine (PE) 1624 
in mammalian cells. 1625 
BIOLOGICAL ACTIVITY REFERENCES 
Phosphatidylserine  
Interaction with PS receptor of macrophages after externalization: apoptosis 
(Fadok et al. 2001; 
Zwaal, Comfurius, 
and Bevers 2005; 
Balasubramanian, 
Mirnikjoo, and 
Schroit 2007; 
Segawa et al. 2014; 
Fadok et al. 1992) 
Inhibition of inflammatory response 
(Fadok et al. 1998; 
Kimani et al. 2014) 
Inhibition of proinflammatory cytokine production, alleviation of arthritis (Yeom et al. 2013) 
Immune system modulation 
(Kimani et al. 2014; 
Tietjen et al. 2014; 
Elliott et al. 2005; 
Fischer et al. 2006; 
Hoffmann et al. 
2005) 
Promotion of the blood-clotting cascade in injury-activated platelets 
(Schick, Kurica, and 
Chacko 1976; 
Schroit and Zwaal 
1991; Connor and 
Schroit 1990; 
Connor et al. 1992; 
Bevers, Comfurius, 
and Zwaal 1983) 
Modulation of the activity of membrane-bound proteins (PkC, Annexin V, Rac 
1) at the intracellular leaflet 
(Powell et al. 2000; 
Swairjo et al. 1995; 
Finkielstein, 
Overduin, and 
Capelluto 2006; 
Lemmon 2008) 
Intracellular signaling pathway in neuronal cells: neurite growth, neuronal cell 
survival, and synaptogenesis 
(Verdaguer et al. 
1999; Huang et al. 
2011; Improta-
Brears, Ghosh, and 
Bell 1999; Kim, 
Huang, and Spector 
2014; Kim 2007; 
Suzuki et al. 2001) 
Phosphatidylethanolamine  
Increase in the percentage of cytokine-producing cells (monocytes and mDC) (Simões et al. 2013b) 
Modulation of mammalian cell membrane curvature 
(Cullis and De 
Kruijff 1978; 
Verkleij et al. 1984) 
Biosynthesis of glycosylphosphatidylinositol-ethanolamine anchors 
(Menon and Stevens 
1992) 
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Post-translational modification of Eukaryotic Elongation Factor 1A 
(Signorell et al. 
2008) 
Regulation of contractile ring disassembly during cytokinesis of mammalian 
cells 
(Emoto and Umeda 
2000; Emoto et al. 
1996) 
Regulation of Golgi membrane fusion in early-divided mitotic cells (Pécheur et al. 2002) 
Cofactor activity in propagation and infectivity of mammalian brain prions (Deleault et al. 2012) 
Covalent modification and recruitment of common autophagosome markers (Hailey et al. 2010) 
Implication with sarcolemmal damage after ischemia and reperfusion 
(Post, Bijvelt, and 
Verkleij 1995) 
Exposure to the outer leaflet in mammalian tumors 
(Stafford and Thorpe 
2011) 
 1626 
  1627 
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Table 2. Occurrences of modified PS and PE in biological samples and their main biological 1628 
activities in mammalian cells. 1629 
OXIDIZED PHOSPHATIDYLSERINE 
Occurrence References 
Formation and externalization during apoptosis 
(Kagan et al. 2002; 
Fabisiak et al. 1998; 
Arroyo et al. 2002; 
Shvedova et al. 2002; 
Koty et al. 2002; 
Matsura et al. 2002; 
Matsura et al. 2004; 
Kagan et al. 2004) 
Formation during oxidative lung injury 
(Tyurina, Kisin, et al. 
2011; Tyurina et al. 
2010; Tyurina, 
Tyurin, et al. 2011) 
Formation in a mouse model of the AD and post-mortem brain samples from AD patients (Maki et al. 2009) 
Formation in rat apoptotic cortical neurons (Tyurin et al. 2008) 
Formation in plasma membranes of apoptotic cells from alcoholic liver disease (Vay et al. 2006) 
Biological activity References 
“Eat-me” signal for phagocytes during clearance of apoptotic cells 
(Greenberg et al. 
2006; Hochreiter-
Hufford and 
Ravichandran 2013; 
Kagan et al. 2002) 
Non-enzymatic scramblase activity (Tyurina et al. 2004) 
Inhibition of peripheral blood T-cells proliferation (Seyerl et al. 2008) 
Upregulation of cytokines production in monocytes and dendritic cells (Silva et al. 2012) 
Inhibition of respiratory burst (Bluml et al. 2008) 
Protection of pulmonary endothelium 
(Birukova et al. 
2006) 
Multi-inhibition of the Toll-like receptor 4 pathway 
(von Schlieffen et al. 
2009) 
Stimulation of the expression of pro-atherogenic genes 
(Afonyushkin, 
Oskolkova, and 
Bochkov 2012) 
Pro-coagulant activity via regulation of PCI (Malleier et al. 2007) 
GLYCATED AND GLYCO-OXIDIZED PHOSPHATIDYLSERINE 
Occurrence References 
CMS detected in human red blood cells membranes (Fountain et al. 1999) 
ALDEHYDE-ALDEHYDE-ADDUCTED PHOSPHATIDYLSERINE 
Occurrence References 
PS-malondialdehyde (PS-MDA) adducts detected in human senile cataractous tissue (Bhuyan et al. 1986) 
N-hexanoyl-PS detected in red blood cells of carbon tetrachloride-treated rats (Hisaka et al. 2010) 
OXIDIZED PHOSPHATIDYLETHANOLAMINE 
Occurrence References 
Direct enzymatic oxidation of membrane PE to 15-hydroxy-eicosatetraenoic acid (15-HETE-
PE) in ionophore-activated human platelets and peripheral monocytes 
(Maskrey et al. 2007) 
Direct enzymatic oxidation of membrane PE to 12-hydroxy-eicosatetraenoic acid (12-HETE-
PE) in ovalbumin-treated murine peritoneal macrophages 
(Morgan et al. 2009) 
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Esterification of enzymatically oxidized arachidonic acid and docosahexaenoic acid into the 
membrane PE pool of thrombin-activated human platelets (12S-HETE-PE) and bacteria-
activated human neutrophils (5-hydroxyeicosatetraenoic acid-PE, 5-HETE-PE). 
(Lloyd T. Morgan et 
al. 2010; Thomas et 
al. 2010; Clark et al. 
2011) 
Direct enzymatic oxidation of membrane PE to 15-keto-eicosatetraenoic acid (15-KETE-PE) 
in human monocytes, macrophages; detection of 15-KETE-PE in bronchoalveolar lavage fluid 
from patients affected by cystic fibrosis 
(Hammond et al. 
2012) 
Spontaneous formation of PE short-chain oxidation products in rat retina (Gugiu et al. 2006) 
Direct oxidation of PE esterified to arachidonic acid and adrenic acid within the ER (Kagan et al. 2016) 
Biological activity References 
Enhanced thrombin generation 
(Zieseniss et al. 
2001; Thomas et al. 
2010) 
Shift in the mobility of soluble CD14 
(von Schlieffen et al. 
2009) 
Inhibition of cytokines generation in human monocytes (Morgan et al. 2009) 
Increase in the frequency of cytokine-producing cells (monocytes and mDC) (Simões et al. 2013a) 
Activation of PPARγ in mouse macrophages 
(Hammond et al. 
2012) 
Inhibition of extracellular traps and enhanced O2- generation in human neutrophils (Clark et al. 2011) 
Pro-coagulant activity via regulation of PCI (Malleier et al. 2007) 
Regulation of MAPK signaling in human airway epithelial cells (Zhao et al. 2011) 
Regulation in the clearance of apoptotic cells and maintenance of immunologic tolerance 
(Uderhardt et al. 
2012) 
Modification in cellular membrane topology 
(Sankhagowit et al. 
2016) 
Mediation of ferroptotic cell death (Kagan et al. 2016) 
GLYCATED AND GLYCO-OXIDIZED PHOSPHATIDYLETHANOLAMINE 
Occurrence References 
Formation in red blood cells and plasma of healthy and diabetic subjects 
(Ravandi et al. 1996; 
Requena et al. 1997; 
Fountain et al. 1999; 
Breitling-Utzmann et 
al. 2001; Nakagawa 
2005; Shoji et al. 
2010; Lertsiri, 
Shiraishi, and 
Miyazawa 1998) 
Formation in glucose-treated LDL 
(Ravandi, Kuksis, 
and Shaikh 2000) 
Formation in diabetic rats 
(Sookwong et al. 
2011) 
CME formation in mitochondrial membranes of different mammalian species 
(Pamplona et al. 
1998) 
Biological activity References 
Promotion of lipid peroxidation 
(Oak, Nakagawa, and 
Miyazawa 2000; 
Nakagawa 2005; 
Annibal et al. 2016) 
Different modulation of the frequency of cytokine-producing cells 
(Simões et al. 2013b; 
Simões et al. 2013a) 
Modulation of the expression levels of proteins involved in several metabolic cell pathways (Annibal et al. 2016) 
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ALDEHYDE-ADDUCTED PHOSPHATIDYLETHANOLAMINE 
Occurrence References 
PE-malondialdehyde (PE-MDA) adducts detected in human senile cataractous tissue (Bhuyan et al. 1986) 
N-hexanoyl-PE detected in red blood cells of carbon tetrachloride-treated rats (Hisaka et al. 2010) 
PE-HNE adducts detected in rats affected by diabetic retinopathy (Bacot et al. 2007) 
IsoLG-PE adducts detected in patients with macular degeneration (Li et al. 2009) 
Para-hydroxyphenylacetaldehyde (pHA-PE) adducts detected in the human atherosclerotic 
intima 
(Heller et al. 2000) 
Biological activity References 
Increase of the macrophages viability in humans (Riazy et al. 2011) 
Endothelial dysfunction, ER curvature and expression of monocyte adhesion molecules in 
HUVEC 
(Guo et al. 2011) 
Increase in platelet aggregation and prothrombinase activity 
(Zieseniss et al. 
2001) 
Inhibition of macrophage phagocytosis 
(Shiratsuchi et al. 
2008) 
Modification in cellular membrane topology (Annibal et al. 2014) 
  1630 
 
 
 56
Table 3. Chemical, physical and enzymatic biomimetic methods that have been used for studying 1631 
APL oxidation and that were coupled with mass spectrometry analysis for the identification and 1632 
structural characterization of oxidized APL   1633 
 System Species Matrix Experimental conditions References 
C
H
E
M
IC
A
L
S
 
Fe2+/H2O2 OH 
Ammonium 
bicarbonate 
buffer (5 mM, 
pH 7.4) 
40 µM FeCl2, 50 mM H2O2, 72 h and 192 
h, 37 °C, dark 
(Simões et al. 
2010) 
Final volume 50 µL, 144 h, and 192 h, 37 
°C dark 
(Domingues et 
al. 2009) 
40 μM FeCl2/EDTA (1:1), 10 mM H2O2, 
37°C, dark 
(Maciel et al. 
2011) 
80 mM FeSO4, 50 mM H2O2, 2 h, 37 °C 
(Annibal et al. 
2016) 
40 µM FeCl2, 50 mM H2O2, 48 h, 37 °C, 
dark 
(Maciel, da 
Silva, et al. 2013; 
Maciel, Faria, et 
al. 2013) 
500 µM FeCl2, 50 mM H2O2, 120 h, 37 
°C, dark 
(Simões et al. 
2013b; Simões et 
al. 2013a) 
Fe2+/ascorbate OH 
Rat cerebral 
cortex 
homogenates 
20 µM FeCl2, 250 µM ascorbate, 6 h, 37 
°C 
(Stadelmann-
Ingrand, 
Pontcharraud, 
and Fauconneau 
2004) 
Cu2+/H2O2 OH 
Phosphate 
buffer saline 
(50 mM, pH 
7.4) 
100 µM CuCl2, 70 mM H2O2, up to 3 h, 
37 °C 
(Khaselev and 
Murphy 1999; 
Gugiu et al. 
2006) 
AAPH ROO 
Hank's 
balanced salt 
solution 
10 mM AAPH, 5 h, 37 °C 
(Zemski Berry et 
al. 2010) 
HaCaT 
Keratinocytes 
(15 x 106) 
30 mM and 50 mM AAPH, 24 h, 37 °C 
(Maciel et al. 
2014) 
Gly-PE O2- 
Tris-HCl 
buffer (10 
mM, pH 7.4) 
15 mol %, 0.3 mol %, 0.05 mol % 
Amadori PE, up to 120 h, 37 °C 
(Breitling-
Utzmann et al. 
2001) 
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Primary rat 
cardiomyocyte
s 
1 mM gly-PE or 1 mM gly-ox-PE, 30 min 
and 16 h 
(Annibal et al. 
2016) 
P
H
Y
S
IC
A
L
 
UVA 1O2 
Ammonium 
bicarbonate 
buffer (5 mM, 
pH 7.4) 
20 min, 75.4 J/cm2 
(Melo, Silva, et 
al. 2013) 
Phosphate 
buffer 
28 °C 
(Gugiu et al. 
2006) 
Rat cerebral 
cortex 
homogenates 
0-90 min, 0-10.8 J/cm2 
(Stadelmann-
Ingrand, 
Pontcharraud, 
and Fauconneau 
2004) 
White light 1O2 
Ammonium 
bicarbonate 
buffer (5 mM, 
pH 7.4) 
Artificial white light irradiation, 30 min, 
90 min, 270 min, 7.2 J/cm2, 21.6 J/cm2, 
64.8 J/cm2 
(Melo, Santos, et 
al. 2013) 
Electrochemistry OH 
1:1 MeOH:20 
mM 
ammonium 
formate 
20µL/min, 37 °C, 2.5 V or 3 V 
(depending on the APL species) 
(Colombo et al. 
2018) 
E
N
Z
Y
M
E
S
 
LOX - 
10 mM 
dehoxycholate
, 0.2 M borate 
buffer 
5.2 KU/mL LOX, 30 min, 95% O2 
(Alwena H 
Morgan et al. 
2010) 
MPO HOX 
Sodium 
phosphate 
buffer (50 
mM) 
5 nM MPO, 100 ng/mL glucose oxidase, 
500 µM NaNO2, 100 µg/mL glucose, 200 
µM DTPA 
(Gugiu et al. 
2006) 
 1634 
  1635 
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Table 4. Oxidative modifications of APL identified by mass spectrometry either in biomimetic 1636 
systems and in vivo: mass shifts observed in the MS spectra when compared with the respective non 1637 
modified APL. Characteristic fragmentations (fatty acid carboxylate anions and neutral losses) 1638 
noticeable in the MS/MS spectra that allow confirming the structural features of the oxidized APL. 1639 
Modification 
Modified fatty acid carboxylate 
anion (m/z) [M-H]- 
Observed neutral loss 
[M-H]- and [M+H]+ 
References 
sn-2 keto (+14 Da) 
295 (oleic acid) 
293 (linoleic acid) 
317 (arachidonic acid) 
341 (docosahexaenoic acid) 
-- 
(Melo, Santos, et al. 2013; 
Hammond et al. 2012; 
Alwena H Morgan et al. 
2010) 
sn-2 hydroxy (+16 Da) 
297 (oleic acid) 
295 (linoleic acid) 
319 (arachidonic acid) 
343 (docosahexaenoic acid) 
[M+H-18]+ 
[M-H-18]- 
 
(Domingues et al. 2009; 
Melo, Santos, et al. 2013; 
Clark et al. 2011; Maskrey 
et al. 2007; Tyurin et al. 
2008; Tyurina et al. 2010; 
Tyurina et al. 2008; Tyurin 
et al. 2009; Alwena H 
Morgan et al. 2010; 
Lloyd T. Morgan et al. 
2010) 
sn-2 dihydroxy (+32 Da) 
313 (oleic acid) 
311 (linoleic acid) 
335 (arachidonic acid) 
359 (docosahexaenoic acid) 
[M-H-36]- 
(18 + 18) 
 
(Tyurin et al. 2009) 
sn-2 hydroperoxy (+32 Da) 
313 (oleic acid) 
311 (LA linoleic acid 
335 (arachidonic acid) 
359 (docosahexaenoic acid) 
[M+H-34]+ 
(Melo, Santos, et al. 2013; 
Tyurin et al. 2008; Tyurin 
et al. 2009; Tyurina et al. 
2008; Tyurina et al. 2010; 
Domingues et al. 2009) 
sn-2 hydroxy-hydroperoxy (+48 
Da) 
329 (oleic acid) 
327 (linoleic acid) 
351 (arachidonic acid) 
375 (docosahexaenoic acid) 
[M+H-34]+ [M+H-18]+ 
 
(Domingues et al. 2009; 
Melo, Santos, et al. 2013; 
Tyurin et al. 2008) 
sn-2 carboxylic acid terminal C9 
187 (linoleic acid) 
 
[M+H-379]+ 
(141+R1=C=O) 
 
(Maciel et al. 2011; 
Domingues et al. 2009; 
Simões et al. 2010) 
sn-2 carboxylic acid terminal C5 
131 (arachidonic acid) 
 
[M-H-190]- 
(58+R2’COOH) 
[M+H-141]+ 
(Maciel, Faria, et al. 2013; 
Gugiu et al. 2006) 
Polar head deamination + 
decarboxylation + oxidation (-29 
Da) 
-- [M-H-58]- (Maciel et al. 2011) 
Polar head decarboxylation + 
oxidation (-30 Da) 
-- [M-H-57]- (Maciel et al. 2011) 
Polar head deamination (-1 Da) -- -- (Melo, Santos, et al. 2013) 
 1640 
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Table 5. Glycative and glyco-oxidative modifications of APL: Characteristic product ions observed in the MS spectra and corresponding neutral 1641 
losses. *This neutral loss was used for the targeted MS detection of modified APL in biological samples. 1642 
Modification 
Structure 
(PE is chosen as an example) 
Observed neutral loss References 
Glucose (+162 Da) 
 
[M+H-84]+ (18+18+18+30) (Simões et al. 2010) 
[M-H-90]- 
(Maciel, da Silva, et 
al. 2013; Maciel, 
Faria, et al. 2013) 
[M+H-120]+ 
(Simões et al. 2010; 
Annibal et al. 2016) 
[M-H-120]- (*) 
(Breitling-Utzmann 
et al. 2001) 
[M+H-150]+ (Simões et al. 2010) 
[M+H-162]+ (Simões et al. 2010) 
[M-H-162]- 
(Ravandi, Kuksis, 
and Shaikh 2000; 
Maciel, da Silva, et 
al. 2013; Maciel, 
Faria, et al. 2013) 
[M-H-249]- 
(87+162) 
(Maciel, da Silva, et 
al. 2013; Maciel, 
Faria, et al. 2013) 
[M+H-303]+ 
(141+162) 
(*) 
(Simões et al. 2010; 
Melo, Silva, et al. 
2013; Ravandi, 
Kuksis, and Shaikh 
2000; Sookwong et 
al. 2011; Nakagawa 
2005) 
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Glucose adducted to α-keto-
etn(+176 Da) 
 
 
[M+H-317]+ 
(141+162+14) 
(Simões et al. 2010) 
Glucuronic acid (+176 Da) 
 
[M-H-263]- 
(87+162+14) 
(Maciel, da Silva, et 
al. 2013) 
[M+H-317]+ 
(141+162+14) 
(Melo, Silva, et al. 
2013; Annibal et al. 
2016) 
Carboxymethyl (+58 Da) 
 
[M+H-199]+ 
(141+58) 
(*) 
(Shoji et al. 2010) 
[M-H-58]- 
(Maciel, da Silva, et 
al. 2013; Melo, 
Silva, et al. 2013) 
-- (Annibal et al. 2016) 
Carboxyethyl (+72 Da) 
 
[M+H-213]+ 
(141+72) 
(*) 
(Shoji et al. 2010) 
-- (Annibal et al. 2016) 
Formamide (+28 Da)  
[M-H-115]- 
(87+28) 
(Maciel, Faria, et al. 
2013; Maciel, da 
Silva, et al. 2013) 
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 1643 
-- 
(Simões et al. 2010; 
Melo, Silva, et al. 
2013) 
Carbamino acid (+44 Da) 
 
-- 
(Melo, Silva, et al. 
2013) 
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 1644 
Table 6. Chromatographic Columns used for LC-MS separation and analysis of modified APL. 1645 
Analyte(s) 
Stationary 
phase 
Column ID Comment References 
4-(dimethylamino)benzoic acid 
(DMABA)-PE 
C18 Gemini® 2.0 mm - (Zemski Berry et al. 2010) 
HETE-PE KETE-PE C18 Luna® 2.0 mm - 
(Lloyd T. Morgan et al. 
2010; Maskrey et al. 2007; 
Clark et al. 2011; 
Hammond et al. 2012; 
Morgan et al. 2009) 
HETE-PE C18 Luna® 2.0 mm 
Separation of the following isobaric species: 
18:0a/12-HETE-PE and 16:0a/12-HETE-PC 
(Thomas et al. 2010) 
HPETE-PE HETE-PE KETE-PE C18 Luna® 2.0 mm Separation of positional isomers of 18:0a/HETE-PE 
(Alwena H Morgan et al. 
2010) 
Short chain oxidation products of 
PE 
C18 Prodigy™ 2.0 mm - (Gugiu et al. 2006) 
Oxidized plasmenyl-PE C18 Ultramex 4.6 mm - 
(Khaselev and Murphy 
1999) 
Short chain and long chain 
oxidation products of PE 
C5 
Discovery® BIO 
Wide Pore 
0.5 mm 
Separation of the following couples of long-chain 
oxidation products: 
(i) PLPE-OH-OH and PLPE-OOH 
(ii) PLPE-OH-OH-OH-OH and 
PLPE-O-OH-OH-OH 
(Domingues et al. 2009) 
Long chain oxidation products of 
PS 
Silica Luna® 2.0 mm - 
(Tyurina et al. 2008; 
Tyurina et al. 2010) 
Gly-PE Gly-PS Silica Spherisorb® 4.6 mm - 
(Ravandi, Kuksis, and 
Myher 1995; Ravandi et 
al. 1996) 
Gly-PE C18 XTerra™ 3 mm - 
(Breitling-Utzmann et al. 
2001) 
Gly-PE Gly-ox PE C5 
Discovery® BIO 
Wide Pore 
0.5 mm 
Separation of two positional isomers for glyco-
oxidized PLPE: 
(i) Gly-PLPE with ketone modification on the polar 
head; 
(ii) Gly-PLPE with ketone modification on the sn-2 
fatty acyl chain 
(Simões et al. 2010) 
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Gly-PS C5 
Discovery® BIO 
Wide Pore 
0.5 mm 
Separation of two positional isomers for glyco-
oxidized POPS: 
(i) Gly-POPS with ketone modification on the polar 
head; 
(ii) Gly-POPS with ketone modification on the sn-2 
fatty acyl chain 
(Maciel, da Silva, et al. 
2013) 
Gly-PS C5 
Discovery® BIO 
Wide Pore 
0.5 mm 
Separation of two isobaric short chain oxidation 
products of PAPS 
(Maciel, Faria, et al. 2013) 
CM-PE, CE-PE C18 XBridge™ 2.1 mm - (Shoji et al. 2010) 
PE adducted to 4,5(E)-Epoxy-
2(E)-heptenal 
HILIC LiChrospher® 4 mm - 
(Zamora and Hidalgo 
2003) 
PE adducted to isoketals C18 
Nucleosil 100-
5® 
2.1 mm - 
(Bernoud-Hubac et al. 
2004) 
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Figures captions. 1717 
Figure 1. Schematic diagram of the chemistry involved in the oxidative and glyco-oxidative 1718 
modifications of APL. The shaded green boxes depict the main modified products. 1719 
Figure 2. Diagram reporting the main biomimetic methods used in the study of APL oxidation 1720 
(Fenton reaction, electrochemical oxidation, AAPH reaction, photosensitization, LOX) and the 1721 
radical chemical reactions induced or catalyzed by each method. 1722 
Figure 3. MS spectrum of a PLPE before and after the oxidation induced by OH radical formed 1723 
during the Fenton reaction (A and B, respectively). The [M+H]+ molecular ion of PLPE is depicted 1724 
at m/z 716.5; the [M+H]+ molecular ion at m/z 748.5 (Panel B) corresponds to the long-chain 1725 
oxidation product of PLPE +2O  (PLPE+ 32 Da). PLPE +2O can be assigned as dihydroxy-PLPE 1726 
and as hydroperoxy-PLPE. The [M+H]+ ion at m/z 764.5 corresponds to the long-chain oxidation 1727 
product of PLPE +3O (PLPE+48Da) and can be identified both as hydroxy-hydroperoxy-PLPE and 1728 
trihydroxy-PLPE. The [M+H]+ ion at m/z 608.4 is attributed to the short chain product 1-1729 
(palmitoyl)-2-(9-oxo-nonanoyl)-PE, in which sn-2 position is esterified to a nonanoic acid with a 1730 
terminal aldehyde in C9. The [M+H]+ ion at m/z 624.4 corresponds to 1-(palmitoyl)-2-(9-carboxy-1731 
nonanoyl)-PE, which is formed by the oxidation of the terminal aldehydic function of 1-(palmitoyl)-1732 
2-(9-oxo-nonanoyl)-PE. Reprinted with permission from Domingues et al. (2009), copyright 2009 1733 
[John Wiley & Sons]. 1734 
Figure 4. (A) Structures of oxidized PS derivatives with modifications in the polar head group 1735 
obtained after the oxidation induced by the OH radical generated by Fenton reaction: terminal 1736 
hydroperoxyacetaldehyde (−13 Da), terminal acetic acid (−29 Da), and terminal acetamide (−30 1737 
Da). (B) Thin Layer Chromatography (TLC) plate under UV light of PS oxidation products with 1738 
modifications in the polar head: lines 1, 2, and 3: oxPLPS; lines 4, 5 and 6: oxPOPS; lines 8, 9 and 1739 
10: oxidized 1,2-dipalmitoyl-sn-3-glycerophosphoserine (DPPS); line 7: PS and PE standards. (C) 1740 
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ESI-MS spectra of PLPS acquired after and before oxidation induced by the OH radical (right and 1741 
left panels, respectively). In Panel C, the ion at m/z 758.4 corresponds to the [M-H]- molecular ion 1742 
of unoxidized PLPS; The oxidized molecular [M-H]- ions were observed at: m/z 774,  PS+O 1743 
(hydroxy-PLPS) m/z 790.4, PLPS +2O, hydroperoxy-PS and/or di-hydroxy-PS (mass shift from 1744 
native PLPS: M+32 Da); m/z 806.4, PLPS +3O hydroxy-hydroperoxy-PS and tri-hydroxy-PS (mass 1745 
shift from native PLPS: M+48 Da); m/z 666.2, 1-(palmitoyl)-2-(9-oxo-nonanoyl)-PS; m/z 682.2, 1-1746 
(palmitoyl)-2-(9-carboxy-nonanoyl)-PS; m/z 728.4; ox-PLPS with Ser polar head modified to 1747 
terminal acetamide (mass shift from native PLPS: M - 30 Da), m/z 745.4, ox-PLPS with Ser polar 1748 
head modified to terminal hydoperoxy-acetaldehyde (mass shift from native PLPS: M-13 Da); m/z 1749 
729.4, ox-PLPS with Ser polar head modified to terminal acetic acid (mass shift from native PLPS: 1750 
M - 29 Da). Reprinted with permission from Maciel et al. (2011), copyright 2011 [Springer]. 1751 
Figure 5. Schematic representation of the oxidative modifications reported for POPE on the 1752 
unsaturated fatty acyl chains and on the polar head group, along with their characteristic mass 1753 
shifts. 1754 
Figure 6. ESI-MS spectrum of gly-PLPE acquired after and before oxidation induced by the OH 1755 
radical (Panels A and B, respectively). In Panel A, the ion at m/z 878.5 corresponds to the [M+H]+ 1756 
molecular ion of glycated PE. In Panel B, the glyco-oxidized [M+H]+ molecular ions were observed 1757 
at: m/z 894.6, gly-PLPE bearing 1 oxygen insertion on the sn-2 linoleoyl chain (mass shift from gly-1758 
PLPE: M+16 Da); m/z 908.6,gly-PLPE bearing 2 oxygen insertions on the sn-2 linoleoyl chain 1759 
(mass shift from gly-PLPE: M+32Da); m/z 926.6, gly-PLPE bearing 3 oxygen insertions on the sn-2 1760 
linoleoyl chain (mass shift from gly-PLPE: M+48 Da); m/z 786.4, glycated 1-(palmitoyl)-2-(9-1761 
carboxy-nonanoyl)-PE, a short chain product of glycated PE. Reprinted with permission from 1762 
Simões et al. (2010), copyright 2010 [Springer]. 1763 
Figure 7. AGEs formed during oxidation of glycated POPS induced by the OH radical (Fenton 1764 
reaction). The ion at m/z 788.4 (POPS + 28 Da) corresponds to the product with a polar head group 1765 
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bearing a terminal formamide, arising from the oxidative cleavage between C1 and C2 of the 1766 
oxidized glucose moiety. The ion at m/z 818.4 (POPS + 58 Da) corresponds to the modified POPS 1767 
with terminal carboxymethyl, arising from the oxidative cleavage between C2 and C3 of the 1768 
glucose moiety, while the ion at m/z 832.4 (POPS+ 72 Da) corresponds to the modified PS with 1769 
terminal carboxyethyl, arising from the oxidative cleavage between C3 and C4 of the glucose 1770 
moiety. The ion at m/z 934.4 was formed by the oxidation of the glucose moiety to glucuronic acid, 1771 
that resulted in a mass increment of 176 Da from native POPS (162 Da + 14 Da = 176 Da). 1772 
Reprinted with permission from Maciel and Silva et al. (2013), copyright 2013 [Elsevier]. 1773 
Figure 8. Full ESI-MS of PE after 2 h of treatment with 2 equivalents of HNE. The schematic 1774 
representation of native DHPE and its different adducts with HNE is also illustrated. In this spectra, 1775 
the ion at m/z 718.6 corresponds to the [M-H]- molecular ion of the native DHPE, the ion at m/z 1776 
874.5 corresponds to the Michael adduct formed by DHPE and HNE (mass shift of 156 Da, 1777 
structure C), the ion at m/z 856.8 corresponds to the Schiff base adduct (mass shift of 138 Da, 1778 
structure B), the ion at m/z 838.9 was assigned as 2-pentylpyrrole-PE (mass shift of 120 Da, 1779 
structure A) arising from the cyclization and dehydration of the Schiff base. Reprinted with 1780 
permission from Guichardant et al. (1998), copyright 1998 [Elsevier]. 1781 
Figure 9. MS spectrum of DPPE incubated with 400 mM hexanal for 1 h at 37 °C (A). The ion at 1782 
m/z 692.52 corresponds to [M+H]+ molecular ion of DPPE; the ion at m/z 774.60 corresponds to the 1783 
Schiff base adduct (mass shift of 82 Da); the ion at m/z 856.68 corresponds to the dimeric adduct 1784 
due, arising from the covalent adduction of a second molecule of hexanal (mass shift of 164 Da), 1785 
the ion at m/z 874.69 was identified as the hydrated form of this dimer; the ion at m/z 936.74 1786 
corresponds to the pyridinium ring adduct formed by covalent adduction of a third hexanal 1787 
molecule, and followed by cyclization and loss of one H2O molecule; the ion at at m/z 954.75 1788 
corresponds to the hydrated precursor of the pyridinium adduct; the ion at m/z 938.76 corresponds 1789 
to the trimeric adduct. The mechanism of the consecutive covalent adductions of hexanal to DPPE 1790 
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is resumed in Panel B. Reprinted with permission from Annibal et al. (2014), copyright 2014 [John 1791 
Wiley & Sons]. 1792 
Figure 10. MS/MS spectrum (Orbitrap HCD activation) acquired in negative ion mode of the [M-1793 
H]- molecular ion of the long chain oxidation product of PAPE bearing 4 inserted oxygen atoms 1794 
(m/z 802.486). The ion at m/z 255.231 corresponds to the R1COO- of palmitic acid; the ion at m/z 1795 
367.210 corresponds to the R2’COO- of oxidized arachidonic acid (arachidonic acid +4O, 303+64 1796 
Da); the ion at m/z 452.277, corresponds to the anion of lyso-PAPE, arising from the neutral loss of 1797 
oxidized arachidonic acid from sn-2 as ketene (-R2’=C=O). The ions at m/z 784.475 and m/z 1798 
766.470 were formed by the neutral losses of 1 and 2 water molecules, respectively (-18 Da and -36 1799 
Da). The schematic representation of two possible isomers, along with their fragmentation 1800 
mechanisms, is also illustrated. 1801 
Figure 11. MS/MS spectrum (Orbitrap HCD activation) acquired in negative ion mode showing the 1802 
fragmentation of a short chain oxidation product of PAPE (m/z 550.343, 1-palmitoyl-2-(5-1803 
oxovaleroyl)-sn-3-glycerophosphoethanolamine). The MS/MS spectrum of the [M-H]- molecular 1804 
ion shows the fragment ions corresponding to the carboxylate anion of palmitic acid (m/z 255.231), 1805 
and the carboxylate anion of the shortened arachidonic acid derivative with terminal aldehydic 1806 
function (5-oxovalerate)  esterified at sn-2 (m/z 115.038). The schematic representation of the 1807 
fragmentation is also illustrated. 1808 
Figure 12. MS/MS spectrum acquired in the negative mode (Ion Trap CID activation) of the PAPS 1809 
bearing 2 inserted oxygens (m/z 814). The fragment ion at m/z 727.4 arises from the neutral loss of 1810 
the Ser moiety from the precursor molecular ion (-87 Da). The schematic representation of the 1811 
fragmentation is also illustrated. 1812 
Figure 13. (A) Reconstructed ion current (RIC) chromatogram of the [M+H]+ molecular ion of 1813 
PLPE long chain oxidation product, at m/z 764.5 (3 inserted oxygen atoms), showing the separation 1814 
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of two constitutional isomers. (B, C) MS/MS spectra acquired in the positive mode of the isomers 1815 
eluted at 18.32 min (identified as the poly-hydroxy derivative) (B) and 21.88 min (identified as the 1816 
hydroperoxy derivative) (C). The following ions were observed in both spectra: ion at m/z 623.6 1817 
([M+H-141]+) which arises from the typical neutral loss of the PE polar head; ion at m/z 313.3, is 1818 
due to the combined loss of 141 Da and R2’=C=O; ion at m/z 467.4, arising from the fragmentation 1819 
of the C9-C10 bond (C9 with a hydroxyl group and C10 with a double bond), combined with the 1820 
loss of polar head (“A1” and “A2” in B and C, respectively); ion at m/z 523.5, arising from the 1821 
fragmentation of the C12-C13 bond (C12 with a hydroxyl group and C13 with a double bond), 1822 
combined with the loss of polar head (fragments “A1” and “A2” in B and C, respectively); ion at 1823 
m/z 646.4, arising from the fragmentation of the C12-C13 bond (C13 with a hydroxyl or 1824 
hydroperoxyl group and C12 with a double bond) (fragments “B1” and “B2” in B and C, 1825 
respectively); ion at m/z 535.4, arising from the fragmentation of the C13-C14 bond (C13 with a 1826 
hydroperoxyl group) combined with the neutral loss of polar head (fragment “C2” in B). In the 1827 
MS/MS spectrum at Panel B, it is possible to see the product ions at m/z 746.6 and m/z 728.6, 1828 
arising from the loss of one (18 Da) and two H2O molecules (36 Da), respectively, pinpointing the 1829 
presence of a polyhydroxy-derivative. In the MS/MS spectrum at Panel C, it is possible to observe 1830 
the product ions at m/z 730.6 and m/z 712.6, formed by the neutral loss of H2O2 (34 Da) and the 1831 
combined losses of H2O2 plus H2O (52 Da), respectively, pinpointing the presence of a hydroxy-1832 
hydroperoxy derivative. Reprinted with permission from Domingues et al. (2009), copyright 2009 1833 
[John Wiley & Sons]. 1834 
Figure 14. (A) MS/MS spectrum acquired in the negative mode (Ion Trap CID activation) of the 1835 
PAPS oxidized in the polar head (PAPS -29 Da) and (B) MS/MS spectrum acquired in the negative 1836 
mode (Orbitrap HCD activation) of PLPS oxidized in the polar head (PLPS -29 Da). Both 1837 
derivatives were formed upon oxidation by the OH radical (Fenton reaction). The MS/MS 1838 
spectrum of PAPS -29 Da (A) shows a base peak at m/z 695.4 corresponding to the fragment ion 1839 
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formed by the neutral loss of acetic acid (-58 Da) from the precursor molecular ion. The fragment 1840 
ion at m/z 255.2 corresponds to palmitic acid (R1COO-) and the fragment ion at m/z 303.3 1841 
corresponds to arachidonic acid (R2COO-). In the MS/MS spectrum of PLPS -29 Da (B) the 1842 
fragment ion at m/z 671.469 corresponds to the neutral loss of acetic acid (-58 Da) from the 1843 
precursor molecular ion. The fragment ion at m/z 255.233 corresponds to palmitic acid (R1COO-) 1844 
and the fragment ion at m/z 303.232 corresponds to linoleic acid (R2COO-). The schematic 1845 
representations of the fragmentations are also reported. 1846 
Figure 15. MS/MS spectrum acquired in the positive mode of gly-PLPE. The neutral loss of 1847 
glycated polar head (-303 Da) is evidenced by the base peak at m/z 575.6; the fragment ion at m/z 1848 
794.6 arises from the neutral loss of 84 Da, due to the elimination of three H2O molecules and one 1849 
H2CO molecule from the precursor molecular ion. The schematic representation of the 1850 
fragmentation leading to the neutral loss of the glycated polar head is also illustrated. Reprinted 1851 
with permission from Simões et al. (2010), copyright 2010 [Springer]. 1852 
Figure 16. MS/MS spectrum acquired in the positive mode of gly-ox-PLPE. The fragment ion at 1853 
m/z 575.5 (base peak) arises from the neutral loss of the oxidized polar head (303+14 Da); the 1854 
fragment ion at m/z 318.1 corresponds to the protonated oxidized polar head group. The schematic 1855 
representation of the fragmentation leading to the neutral loss of the oxidized glycated polar head is 1856 
also illustrated. Reprinted with permission from Simões et al. (2010), copyright 2010 [Springer]. 1857 
Figure 17. MS/MS spectrum acquired in the negative mode (Orbitrap HCD activation) of gly-1858 
PLPE. The fragment ion at m/z 714.508 arises from the neutral loss of glucose (-162 Da). The 1859 
fragment ions at m/z 255.233 and m/z 279.233 correspond to the unmodified R1COO- and R2COO-, 1860 
respectively. The fragment ions at m/z 756.519 and m/z 786.529 arise from the neutral losses of 90 1861 
Da (-C3H6O3), and 120 Da (- C4H8O4) from the precursor ion, respectively, and arise from 1862 
characteristic fragmentation patterns of the glucose moiety upon negative ion mode MS/MS. The 1863 
schematic representation of the fragmentation is also reported. 1864 
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Figure 18. MS/MS spectrum acquired in the negative mode (Orbitrap HCD activation) of gly-1865 
PLPS. The fragment ion at m/z 758.497 arises from the neutral loss of glucose (-162 Da). The base 1866 
peak at m/z 671.466 arises from the combined neutral losses of glucose and aziridine-2-carboxylic 1867 
from the precursor ion (162+87 = 249 Da). The fragment ions at m/z 255.233 and m/z 279.233 1868 
correspond to the unmodified R1COO- and R2COO-, respectively. The ion at m/z 830.519 arises 1869 
from the neutral loss of 90 Da (-C3H6O3). The schematic representation of the fragmentation is also 1870 
reported. 1871 
Figure 19. (A) Reconstructed ion current (RIC) chromatogram of the [M-H]- molecular ion of gly-1872 
POPS long chain oxidation product, at m/z 936.4 (mono-keto-derivative) showing the separation of 1873 
two constitutional isomers. (B) MS/MS spectrum and (C) scheme of fragmentation of the isomer 1874 
that eluted at 11.0 min; in the MS/MS spectrum at Panel B, the fragment ion at m/z 673.3 (base 1875 
peak) arises from the neutral loss of 263 Da, which is due to the loss of aziridine-2-carboxylic acid 1876 
(87 Da) adducted to the glucuronic acid moiety (162+14 = 176 Da), confirming the insertion of one 1877 
oxygen atom on the glycated polar head; the fragment ion at m/z 760.4 can be attributed to the 1878 
neutral loss of glucuronic acid (176 Da) and further confirms the oxidation of the glucose moiety. 1879 
(C) MS/MS spectrum and (D) scheme of fragmentation of the isomer eluted at 19.7min; in the 1880 
MS/MS spectrum at Panel B, the fragment ion at m/z 687.4 (base peak) arises from the neutral loss 1881 
of 249 Da, which corresponds to the aziridine-2-carboxylic acid (87 Da) adducted to the glucose 1882 
moiety (162 Da), confirming that the keto insertion (+14 Da) is located on the oleoyl chain of gly-1883 
POPS; the fragment ion at m/z 774.3 (neutral loss of glucose, 162 Da) also shows that the glucose 1884 
moiety does not bear any oxidative modification. Reprinted with permission from Maciel et al. 1885 
(2013), copyright 2013 [Elsevier]. 1886 
Figure 20. MS/MS spectrum acquired in the negative mode of the advanced gly-ox-POPS end 1887 
product at m/z 818.4 (cleavage in the C2-C3 bond of the glucose moiety). In this spectrum, the 1888 
fragment ion at m/z 673.4 (base peak) arises from the neutral loss of 145 Da, that corresponds to the 1889 
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Ser moiety adducted to a carboxymethyl group, formed by the oxidative cleavage of glucose (87 + 1890 
58 Da). This fragmentation pathway confirms that the precursor ion at m/z 818.4 is a PS AGE in 1891 
which the glucose moiety has been shortened by an oxidative cleavage between C2 and C3. The 1892 
minor fragment ion at m/z 760.5 arises from the neutral loss of a carboxymethyl moiety from the 1893 
precursor ion (-58 Da) and further confirms that an oxidative cleavage occurred between C2 and C3 1894 
of glucose. Reprinted with permission from Maciel et al. (2013), copyright 2013 [Elsevier]. 1895 
Figure 21. MS/MS spectrum acquired in the negative mode of the IsoLG–PE pyrrole adduct at m/z 1896 
1031; the fragment ion at m/z 768 arises from the neutral loss of R2=C=O; the fragment ion at m/z 1897 
512 is due to the combined losses of R2COOH and R1COOH; the fragment ion at m/z 415 arises 1898 
from the neutral losses of the polar head, modified as pyrrole adduct (361 Da), and  R1COOH; the 1899 
fragment ion at m/z 391 arises from the neutral losses of the polar head modified as pyrrole adduct 1900 
(361 Da) and R2COOH.; the fragment ions at m/z 279 and m/z 255 are R2COO- and R1COO-, 1901 
respectively; the fragment ion at m/z 153 is due to the combined neutral losses of the polar head 1902 
modified as pyrrole adduct (361 Da) and of R1COOH and R2COOH. The schematic representations 1903 
of the fragmentations are also illustrated. Reprinted with permission from Bernoud-Hubac et al. 1904 
(2004), copyright 2004 [Elsevier]. 1905 
Figure 22. MS/MS spectrum acquired in negative ion mode of IsoK–PE Schiff base adduct at m/z 1906 
1035; the fragment ion at m/z 772 arises from the neutral loss of R2=C=O; the combined neutral 1907 
losses of R2COOH and R1COOH led to fragment ion at m/z 516; the fragment ion at m/z 415 is 1908 
formed by the combined neutral losses of the polar head modified as Schiff base adduct (-365 Da) 1909 
and R1COOH; the fragment ion at m/z 391 arises from the combined neutral losses of the polar head 1910 
modified as Schiff base adduct (-365 Da) and R2COO-; the fragment ions at m/z 279 and m/z 255 1911 
are R2COO- and R1COO-, respectively; the fragment ion at m/z 153 arises from the neutral losses of 1912 
the polar head modified as Schiff base adduct (-365 Da) and of R1COOH and R2COOH. The 1913 
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schematic representations of the fragmentations are also illustrated. Reprinted with permission from 1914 
Bernoud-Hubac et al. (2004), copyright 2004 [Elsevier]. 1915 
Figure 23. Positive ion mode multistage tandem MS spectra of a DPPE-hexanal Schiff base adduct. 1916 
(A) MS/MS spectrum of the DPPE-hexanal Schiff base adduct; the fragment ion at m/z 551.51 1917 
corresponds to the diacylglyceride fragment ion, arising from the neutral loss of the 1918 
phosphoethanolamine moiety covalently linked to hexanal (-224 Da); the fragment ion 1919 
corresponding to the modified polar head group can be seen at m/z 224.15 and was selected for 1920 
further fragmentation. (B) The MS3 spectrum of phosphoethanolamine-hexanal Schiff base product 1921 
ion; the fragment ion at m/z 126.10 corresponds to the of the vinylamine-hexanal Schiff base adduct 1922 
due to the neutral loss of phosphoric acid from the precursor ion (-98 Da); this fragment ion at m/z 1923 
126.10 was further isolated and fragmented. (C) The MS4 spectrum of the vinylamine-hexanal 1924 
Schiff base product ion; several peaks (m/z 112.34, 98.15, 83.97, 69.98, 55.99) arise from the 1925 
sequential mass losses of 14 Da, which confirm the presence of a hexanal alkyl chain adducted to 1926 
the polar head. The schematic representations of the fragmentations are also illustrated. Reprinted 1927 
with permission from Annibal et al. (2014), copyright 2014 [John Wiley & Sons]. 1928 
Figure 24. Schematic representation of the PIS approach based on D6-DMABA derivatization 1929 
proposed for the identification of oxidized PE in lipid extracts from RAW 264.7 cells. 1930 
